By MobiHealthNews' tally, the last three months have hosted at least 92 digital health funding rounds totalling just over $3.8 billion – a marked increase over Q4 2019's 55 raises of $1.7 billion.
After something of a cool start, digital health investors finished the fourth quarter of 2020 strong with a collection of nine-figure raises from well-known health tech names. Verily led the pack here with a late-breaking $700 million raise, but the last few weeks also saw noteworthy buzzer-beaters from Bright Health ($500 million) Olive ($225.5 million), Everlywell ($175 million) and Cityblock Health ($160 million).
Big fundraising numbers were also the story of 2020 as a whole. In a calendar year that didn't adhere to anyone's expectations, digital health and health tech found unprecedented interest from patients, providers and investors alike.
That last group bankrolled 372 funding rounds for 351 companies, and by MobiHealthNews' count pumped about $13.8 billion into the digital health sector. The year's raises were head and shoulders above its predecessors, which logged 251 announcements for $7.2 billion (2019) and 244 rounds for $7.7 billion (2018).
To see our entire breakdown, read on below for the full list of funding news MobiHealthNews tracked in 2020. These entries are ordered by size with multiple raises by the same company broken out into separate entries. The companies' names also include links to our initial coverage of the raise.
| Company | Round/Series | Amount (M) | Quarter | Investors | What's it for | What they do | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verily | Unspecified | $700 | Q4 | Alphabet, Silver Lake, Temasek, Ontario Teachers' Pension Plan and others | The investments will be used to expand some of Verily’s leading commercial businesses, such as Project Baseline. | Verily serves as Alphabet’s research arm that develops tools and devices to collect, organize and activate health data. | ||||||||||||||||
| Bright Health | Series E | $500.00 | Q3 | Tiger Global Management, T. Rowe Price Associates and Blackstone, NEA, Bessemer Venture Partners and Greenspring Associates. | These funds, in addition to existing capital, will be used to help the company expand into new geographies, Bright Health said. | It operates in 43 markets across 13 states in the U.S. and currently offers individual, family and Medicare Advantage plans. Additionally, the tech-enabled company runs a consumer-minded platform consisting of web tools and a mobile app. | ||||||||||||||||
| XtalPi | Series C | $319.00 | Q3 | SoftBank Vision Fund 2, PICC Capital, Morningside,Tencent, Sequoia China, China Life and SIG | XtalPi plans to use this funding to help make the pharmaceutical R&D process more efficient by expanding its ID4 platform. | Its platform combines quantum physics, AI and cloud computing algorithms to assess how drugs react at a molecular level in order to help pharmaceuticals progress through clinical trials. | ||||||||||||||||
| ClassPass | Series E | $285 | Q1 | L Catterton, Apax Digital and Temasek | The company said that the new funds will help further scale its platform internationally. | The ClassPass platform allows users to sign up for a single subscription membership that allows them to participate in local fitness classes in exchange for credits. | ||||||||||||||||
| Alto | Series D | $250 | Q1 | Softbank's Vision Fund 2, Greanoaks Capital, Jackson Square Ventures and others | Alto has not shared its plans for the funds. | The core of Alto’s digital pharmacy business is a tech-enabled platform for free, same-day medication delivery. | ||||||||||||||||
| Recursion Pharmaceuticals | Series D | $239.00 | Q3 | Leaps by Bayer, Casdin Capital, Catalio Capital Management, Laurion Capital Management, Samsara BioCapital and others. | The funds will help Recursion fuel the clinical development of its therapy.peutic pipeline, and support continued investment into the development of its technology. | Recursion is an artificial intelligence drug discovery company, | ||||||||||||||||
| Olive | Venture round | $225.50 | Q4 | Tiger Global, General Catalyst, Drive Capital, Silicon Valley Bank, GV, Sequoia Capital Global Equities, Dragoneer Investment Group and Transformation Capital Partners | These funds will speed up product development as it plans to unveil additional platform capabilities in the new year. | Olive offers its customers an "AI Workforce" that's designed to automate a selection of tedious, high-volume administrative tasks for healthcare organizations. | ||||||||||||||||
| Oscar | Series C | $225 | Q2 | Alphabet, General Catalyst, Khosla Ventures, Lakestar, Thrive Capital and Baillie Gifford | The company is planning to use this latest infusion of cash to expand its footprint. | Oscar offers direct-to-consumer health insurance. Currently it has plans for individuals and families, businesses, and Medicare Advantage plans. | ||||||||||||||||
| ICON Health & Fitness | Growth round | $200 | Q4 | L Catterton and Pamplona Capital Management | ICON is accelerating its ability to sell its various connected devices and deliver fitness content through its iFit digital platform. | ICON is the parent company of a range of connected consumer fitness equipment brans like NordicTrack, Freemotion and iFit. | ||||||||||||||||
| Ro | Series C | $200.00 | Q3 | General Catalyst, FirstMark Capital, Torch, SignalFire, TQ Ventures, Initialized Capital, 3L, BoxGroup and the Chernin Group | The company is adding remote patient monitoring, new diagnostic testing and urgent care to its offerings. | Ro began as a men's sexual health and wellness platform, and now hosts several brands delivering direct-to-consumer health products. | ||||||||||||||||
| Amwell | Series C | $194 | Q2 | Allianz X and Takeda | The company plans to use the new money to help expand its technology.ogy and services and help providers scale. | Amwell is among the largest consumer and enterprise telehealth providers. | ||||||||||||||||
| Everlywell | Series D | $175 | Q4 | BlackRock, the Chernin Group, Foresite Capital, Greenspring Associates, Lux Capital, Morningside Ventures Portfolia, Goodwater Capital, Highland Capital Partners and Next Coast Ventures | EverlyWell wants to flesh out its virtual care offerings, scale up its testing capabilities and infrastructure, and use its testing system to support clinical research. | The startup's online consumer storefront offers home lab tests spanning the range of general wellness, nutrition, heart health, blood sugar, sexual health and – as of 2020 – COVID-19. | ||||||||||||||||
| Grand Rounds | Unspecified | $175.00 | Q3 | The round was led by the Carlyle Group. | According to the company, the new funds will go towards growing its “clinical navigation and virtual primary care.” | The California-based company was founded in 2011 and started out as a second opinions site, but then pivoted to the health navigation space. | ||||||||||||||||
| Cityblock Health | Series C | $160 | Q4 | Cityblock will be extending its reach into new regions and building out its offerings, such as a maternity care program. | The startup uses its tech platform to address health disparities and provide cost-effective care services. | |||||||||||||||||
| KRY | Series C | $152 | Q1 | Ontario Teachers’ Pension Plan’s Teachers’ Innovation Platform, Index Ventures, Creandum and Accel | KRY said in its announcement that the new funding will power its push into additional European markets. | Patients who input their symptoms through KRY's app can schedule a 15-minute video consultation with a healthcare professional via mobile phone, tablet or browser. | ||||||||||||||||
| Concerto HealthAI | Series B | $150 | Q1 | Declaration Partners, Maverick Ventures, AllianceBernstein PCI and SymphonyAI Group | The new funds will help the company focus on developing its products. and services, expand beyond precision oncology and into new therapeutic areas, and develop commercial patient offerings. | Concerto works on a clinical insight generation platform that employs real-world data in its analysis. | ||||||||||||||||
| Element Science | Series C | $145.60 | Q1 | Deerfield Healthcare, Qiming Venture Partners USA, Cormorant Asset Management, Invus Opportunities, Third Rock Ventures and Google Ventures | These funds will continue to support clinical testing of the Jewel Patch product, and the development of more Jewel devices for other clinical areas. | Element Science is currently conducting clinical testing on its primary product, the Jewel Patch Wearable Cardioverter Defibrillator. | ||||||||||||||||
| insitro | Series B | $143 | Q2 | Andreessen Horowitz, Canada Pension Plan Investment Board, T. Rowe Price Associates, BlackRock, Casdin Capital, HOF Capital, WuXi AppTec's Corporate Venture Fund, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, and Alexandria Venture Investments | The funds will support the continued construction of its technology, and allow it to begin pursuing genetically validated targets and therapeutics among certain patient populations. | insitro analyzes genetic, phenotypic and clinical data to find likely candidates for new treatments. | ||||||||||||||||
| Oscar | Unspecified | $140 | Q4 | Tiger Global Management, Dragoneer, Baillie Gifford, Coatue, Founders Fund, Khosla, Lakestar and Reinvent | Oscar anticipates more growth in its future, and wants to leverage its new funding to reach more potential enrollees. | The insurtech company offers direct-to-consumer health plans that seek out and guide members toward optimal and cost-effective care options. | ||||||||||||||||
| DispatchHealth | Series C | $135.80 | Q2 | Optum Ventures, Alta Partners, Questa Capital, Echo Health Ventures, Oak HC/FT and Humana. | With these funds, DispatchHealth plans to grow its services in cities they already occupy and into new locations. It also will begin offering additional services available on its platform. | Patients and their providers can request services by calling in by phone – or via the mobile app or website. A team of medical professionals is then sent to the patient’s house within two hours of the request to provide the necessary care. | ||||||||||||||||
| Alignment Healthcare | Series C | $135 | Q1 | Fidelity Management & Research Company, Durable Capital Partners L.P. and multiple funds and accounts advised by T. Rowe Price Associates | Alignment said that the new funds would help the insurer strengthen its tech platform and plan offerings as it looks to speed up its growth within the Medicare Advantage market. | Alignment is a Medicare Advantage insurer that relies on a tech platform to manage its members' shifting data in real time. | ||||||||||||||||
| Iora Health | Series F | $126 | Q1 | Premji Invest, Cox Enterprise, Temasek F-Prime Capital, Devonshire Investors, .406 Ventures, Flare Capital Partners, Polaris Partners and Khosla Ventures | The company plans to use the new funds to build a Medicare Certified EHR system. | The Boston-based startup provides patients with care at brick-and-mortar locations, as well as through digital tools including text messages, emails and calls. | ||||||||||||||||
| Atomwise | Series B | $123.00 | Q3 | B Capital Group, Sanabil Investments, DCVC, BV, Tencent, Y Combinator, Dolby Family Venture and AME Cloud Ventures. | The new funds are going to be put toward its internal drug development.nt efforts and used to grow its partnership programs. | The company uses artificial intelligence, specifically “convolution neural networks,” in order to assist with drug discovery efforts. | ||||||||||||||||
| Sema4 | Series C | $121.00 | Q3 | BlackRock, Deerfield Management Company, Moore Strategic Ventures, Blackstone, Section 32, Oak HC/FT, Decheng and Connecticut Innovations | The funds will help Sema4 continue to grow and bring new "world-renowned partners" to its team. | The spinout promotes data platforms focused on intelligent use of health research data, data-driven precision oncology, women's reproductive health and population health management. | ||||||||||||||||
| 98point6 | Series E | $118 | Q4 | Growth Fund of L Catterton, Activant Capital, Goldman Sachs Merchant Banking Division and other unnamed investors. | 98Point6's newest funding will support R&D investment and further expansion of the startup's medical practice for employers, health plans and retail customers. | The company's on-demand primary care services for consumers and payers use AI to collect information about the user, build a patient profile and match them with a practitioner. | ||||||||||||||||
| Lyra Health | Series D | $110.00 | Q3 | Addition, Adams Street Partners, Casdin Capital, Glynn Capital, Greylock, IVP, Meritech Capital Partners, Providence Ventures, Tenaya Capital and former Starbucks CEO Howard Schultz | The funds will help address new demand in the employee mental health market and expand Lyra Blended Health, its video teletherapy service. | Lyra’s platform matches employees and their dependents to mental healthcare professionals and personalized, evidence-based treatments. | ||||||||||||||||
| Sophia Genetics | Series F | $110.00 | Q4 | aMoon, Hitachi Ventures, Credit Suisse and the Pictet group | Sophia Genetics' AI platform translates multiple sources of complex medical data on cancer and rare diseases into clinical insights for providers. | The new funding round will boost the company’s penetration in the U.S. and Asian markets, as expand the platform's multimodal capabilities. | ||||||||||||||||
| Strava | Series F | $110 | Q4 | TCV, Sequoia Capital, Dragoneer Investment Group, Madrone Capital Partners, Jackson Square Ventures and Go4it Capital | Strava plans to build up its features, support its global community and expand to better serve more athletes. | Strava is a consumer cycling and running platform with social features. | ||||||||||||||||
| Tonal | Unspecified | $110.00 | Q3 | L Catterton, Sapphire Sport, Shasta Ventures, Mayfield, Evolution Media and THVC, Delta-v Capital, the Amazon Alexa Fund, Mouse Partners, basketball players Stephen Curry and Paul George and professional golfer Michelle Wie. | With this raise, it aims to accelerate marketing initiatives while simultaneously ramping up its supply chain and logistics to meet demand. The company will also be targeting new software-based additions to its product, new fitness content and a research project with the Mayo Clinic. | Tonal offers a special connected exercise machine with a AI-powered fitness software, all focused on the goal of strength training. | ||||||||||||||||
| Olive | Unspecified | $106.00 | Q3 | General Catalyst and Drive Capital, Ascension Ventures, Oak HC/FT and SVB Capital. | The company did not specify how it would be deploying the new funds.s. | Olive is a startup that develops artificial intelligence and automation software for providers. | ||||||||||||||||
| Cedar | Series C | $102.00 | Q2 | led by Andreessen Horowitz. | The company said the new funds will be put towards expanding its overall offerings. | The company focuses on helping to guide patients through their medical bills and payments. | ||||||||||||||||
| LinkDoc Technology | Series D+ | $102.00 | Q3 | The company's support came from an undisclosed collection of prior backers, as well as newcomers such as CICC Capital, Youshan Capital and iFOF. | The company said it plans to continue fleshing out its big data platform and the tools within it. | The company is a cloud-based platform offering a big data repository of medical data for clinical trial and clinical AI. | ||||||||||||||||
| Avail Medsystems | Series B | $100 | Q4 | D1 Capital Partners, 8VC, Lux Capital, Coatue, Sonder Capital, Playground Global, Baidu Ventures and Refractor Capital | The money will help push into new clinical specialties, further improve access to medical expertise, and enable more rapid adoption of new medical technologies. | The Palo Alto, California company's technology allows surgical teams to virtually consult with outside experts while they are in the midst of a procedure. | ||||||||||||||||
| Biofourmis | Series C | $100.00 | Q3 | SoftBank Vision Fund 2, Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI. | As part of the shift, Biofourmis said that it would be using the new capital to develop, validate and commercialize digital therapeutics. | Biofourmis is a Boston-based predictive-care startup that's leaning more and more into digital therapeutics. | ||||||||||||||||
| Carbon Health | Series C | $100 | Q4 | Dragoneer Investment Group, Brookfield Technology Partners, DCVC and Builders VC | These funds will help scale Carbon's business across the country, as well as support its ongoing push into the enterprise and employer market. | Carbon Health's approach blends in-person visits at a clinic or pop-up site with virtual care through its app | ||||||||||||||||
| Cue Health | Series C | $100.00 | Q2 | Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation, ACME Capital and other unnamed investment firms all participated in the raise. | The new funds will be used to scale the manufacturing of its platform. | Cue is a rapid diagnostics startup now working on a connected testing device. | ||||||||||||||||
| Heal | Series D | $100.00 | Q3 | Humana | In addition to aligning the two companies' interests and delivering Heal's home care services to Humana members, the strategic investment will help Heal push into new regions including Chicago, Charlotte and Houston. | Founded as a house call coordination app, Heal's service has expanded to support backend administrative work, telehealth follow-ups and pelepsychology services. | ||||||||||||||||
| Medly | Series B | $100.00 | Q3 | Volition Capital, Greycroft, Horsley Bridge and Lerer Hippeau | The company plans to use the new funds to grow its platform and services. | The tech-enabled pharmacy lets patients schedule same-day delivery over the phone, through text messages or an app. | ||||||||||||||||
| Mindstrong | Series C | $100 | Q2 | Undisclosed | The company plans to use the latest funds to scale its business. | Mindstrong's digital mental health platform combines telehealth, care management and digital biomarkers. | ||||||||||||||||
| Verana Health | N/A | $100 | Q1 | GV, Bain Capital Ventures, Casdin Capital and Define Ventures | The company plans to expand its analytics to integrate imaging, genomics and claims data sources. | Verana's curates and analyzes real-world clinical data within ophthalmology and neurology. | ||||||||||||||||
| Virta | Series C | $93 | Q1 | Caffeinated Capital, Venrock, Obvious Ventures, Creandum, Playground Global and SciFi VC | The new capital will be put towards growing the company’s product and reach. | Virta's digital Type 2 diabetes coach combines a digital offering of coaching and remote monitoring with a nutrition-based ketogenic diet. | ||||||||||||||||
| Medable | Series C | $91 | Q4 | Sapphire Ventures, GSR Ventures, PPD, Inc and Streamline Ventures | The new infusion of cash will go towards helping to build new technologies in the clinical trial space. | The startups has created a software platform that brings together data and resources from different stakeholders in the industry including clinicians, patients and researchers. | ||||||||||||||||
| Hinge Health | Series C | $90 | Q1 | Bessemer Venture Partners, Lead Edge Capital, Insight Partners, Atomico, 11.2 Capital, Quadrille Capital and Heuristic Capital | Hinge Health’s leaders believe that the time is right to dip into private equity so that the MSK company can expand its product lineup and workforce. | The San Francisco-based company’s digital platform uses wearable sensors and one-on-one health coaching to deliver in-home MSK therapy. | ||||||||||||||||
| Pear Therapeutics | Series D | $80 | Q4 | SoftBank Vision Fund 2, Forth Management, Pilot House, Sarissa Capital, Shanda Group, QUAD Investment Management, Temasek, 5AM Ventures, Arboretum Ventures, JAZZ Venture Partners, Novartis, CrimsoNox and EDBI | Pear will be working to secure reimbursement coverage for its products that are already on the market, and to continue development for those yet to come. | Pear is known for its selection of FDA-cleared and in-development prescription digital therapeutics. | ||||||||||||||||
| Spring Health | Series B | $76 | Q4 | Tiger Global, GinerBreak Capital and Operator Partners, Northzone, Rethink Impact, William K. Warren Foundation, Work-Bench, SemperVirens, Able Partners, True Capital and individual investors | The company said it will be using the new funds to generally refine its offering and expand its capabilities, as well as to triple its New York-based team. | Spring Health is a behavioral health benefits company targeting employers. | ||||||||||||||||
| Calm | Series C | $75 | Q4 | Lightspeed Venture Partners, TPG, Insight Venture Partners, Marc Benioff and funds managed by Goldman Sachs Asset Management. | The company plans on using the new funds to grow its business globaly. ally and expand its foothold in the employer health market. | The company's known for its guided meditation app that helps users with sleep and relaxation. | ||||||||||||||||
| Doctor On Demand | Series D | $75.00 | Q3 | General Atlantic and prior investors | The new money will fuel growth and expand access among U.S. patients. | The San Francisco-based company provides virtual care services directly to consumers as well as through arrangements with health plans and employers. | ||||||||||||||||
| Lyra Health | Series C | $75 | Q1 | IVP, Meritech Capital Partners, Casdin Capital, Crown Venture Fund, Glynn Capital, Greylock Partners, Providence Ventures, Tenaya Capital and Venrock | Lyra Health plans to expand its platform and network of mental health providers. | Lyra’s platform primarily serves to match employees and their dependents to mental health care professionals and personalized, evidence-based treatments. | ||||||||||||||||
| MDLive | crossover equity/debt financing | $75.00 | Q3 | Sixth Street Growth and other unnamed investors. | The company said it would be prioritizing the expansion of its Virtual Primary Care platform with these funds, and will also be working to launch new supporting products and services for its members. | MDLive provides a telehealth platform staffed by a network of certified clinicians capable of delivering virtual urgent care, dermatology, therapy and psychiatry services. | ||||||||||||||||
| Truepill | Series C | $75.00 | Q3 | Oak HC/FT, Optum Ventures, TI Platform Management, Sound Ventures and YCombinator. | The company plans to use the funds to roll out a new at-home lab testing. The idea is that the company will combine testing, telehealth services and digital pharmacies. | The company works with digital health brands, pharma manufacturers and health plans, to connect patients to telehealth and digital pharmacy services. | ||||||||||||||||
| Eargo | Series E | $71.00 | Q3 | Gilde Healthcare, Longitude Capital, New Enterprise Associates, the Charles and Helen Schwab Foundation and Nan Fung Life Sciences. | The new funds will go towards expanding the commercialization of the product. product. | The startup has developed app-connected, rechargeable hearing devices that can be purchased directly by the consumer. | ||||||||||||||||
| LetsGetChecked | Series C | $71 | Q2 | Illumina Ventures, HLM Venture Partners, Deerfield, CommonFund Capital and Angeles Investments, Transformation Capital, Optum Ventures and Qiming Venture Partners USA | The company said these funds will help build up its manufacturing, supply and testing capacity for COVID-19. | LetsGetChecked provides consumer customers with a range of at-home testing kits, such as ones for hormone levels, sexually transmitted infections, liver performance, nutrition and COVID-19. | ||||||||||||||||
| Sight Diagnostics | Series D | $71.00 | Q3 | Koch Disruptive Technologies, Longliv Ventures and OurCrowd | The company said it plans to push into new regions and fuel R&D efforts so that its platform can be employed for additional diseases. | Sight Diagnostics offers an FDA 510(k)-cleared complete blood count analyzer for use by frontline healthcare workers. | ||||||||||||||||
| Cera Care | N/A | $70 | Q1 | Kairos | The funding coincided with Cera Care's launch of its SmartCare technology platform. | SmartCare utilises machine learning and data analytics to predict the onset of health deteriorations in patients before they manifest. | ||||||||||||||||
| Innovaccer | Series C | $70 | Q1 | Steadview Capital, Tiger Global, Dragoneer, Westbridge, Mubadala and Microsoft’s M12 | The company wrote in its announcement that these funds would be used to further strengthen its data-driven platform. | By using artificial intelligence and data analytics, Innovaccer’s products handle a slew of processes for healthcare organizations. | ||||||||||||||||
| AliveCor | Series E | $65 | Q4 | OMRON, Khosla Ventures, SP Global Partners, Qualcomm Ventures and Bold Capital Partners | The capital will be used to enhance the growth of AliveCor’s remote-cardiology platform by adding telehealth, detection and condition-management services for providers and healthcare institutions. | AliveCor offers a range of AI-enabled personal ECG devices and related services for consumers and providers. | ||||||||||||||||
| Eko | Series C | $65 | Q4 | Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, 3M Ventures and other investors | Eko will expand use of its telehealth and screening algorithm within the clinic, and also launch of an at-home cardiopulmonary monitoring program. | Eko is known for combining ECG-enabled digital stethoscope devices with monitoring and analysis algorithms. | ||||||||||||||||
| FITURE | Series A | $65.00 | Q4 | Tencent, Sequoia Capital China, Bertelsmann Asia Investments, C Ventures, Cathay Capital, BA Capital, CPE and All-Stars Investment | FITURE is focusing on R&D and developing new interactive content. | The Chengdu, China-based startup is working on an in-home smart screen that delivers fitness courses, data tracking and other workout features. | ||||||||||||||||
| Virta | Series D | $65 | Q4 | Sequoia Capital Global Equities | The company said the new funds will help it grow and support the new demands in the diabetes space. | Virta offers digital coaching for diabetes and related conditions. | ||||||||||||||||
| Aledade | Series C | $64 | Q2 | OMERS Growth Equity, California Medical Association, Meritech Capital, Echo Health Ventures, CVF and GV | The funds will help it to continue growing new and existing ACOs in addition to value-based contracts with public and commercial health plans. | Aledade partners with providers to build tech-enabled accountable care organizations. | ||||||||||||||||
| Exscientia | Series C | $60 | Q2 | Novo Holdings, Evotec, Bristol Myers Squibb and GT Healthcare Capital Partners | The money will expand the various projects in Exscientia's portfolio and pipeline, and help it launch new efforts. | Exscientia has a platform that uses AI to design novel compounds for synthesis and clinical development. | ||||||||||||||||
| nference | Series C | $60 | Q4 | Matrix Capital Management, Matrix Partners, Mayo Clinic Ventures and NTTVC | The company said it will put the new funds towards growing its product line. | The company has developed software that makes it easy for researchers, doctors and industry players to search for biomedical information. | ||||||||||||||||
| Patient Ping | Series C | $60 | Q2 | Andreessen Horowitz, F-Prime Capital, GV, and Transformation Capital led the round with participation from existing investors. | The latest funding, which actually closed a year ago but was no announced until recently, is expected to help the company expand its geographical footprint and reach to move providers. | The company is able to coordinate patient care by giving a notification to providers when a patient receives care at another institution. | ||||||||||||||||
| Tempo | Series B | $60.00 | Q3 | Northwest Venture Partners, General Catalyst, DCM, Bling Capital, SignalFire, Founder Fund and Y Combinator | This infusion of cash is slated to be used to increase manufacturing capacity, and open a second production studio. | Tempo's in-home fitness system includes a screen and 3D-vision camera, which can scan the user’s movements 30 times per second, through which it delivers live workout classes. | ||||||||||||||||
| Withings | Series B | $60.00 | Q3 | Gilde Healthcare, Idinvest Partners, Pbifrance, BNP Paribas Development, ODDO BHF Private Equity and Adelie Capital | Withings aims to scale its B2B division globally, and accelerate development of new consumer devices. | Best known as the maker of smart health devices for consumers, Withings has lately added a focus on B2B connected devices. | ||||||||||||||||
| Nanox | Unspecified | $59.00 | Q3 | Unnamed global investors | The funds intended to support worldwide rollouts of the Nanox.ARC. | The Israeli company is developing a two-pronged offering comprising an in-hospital imaging device and a companion cloud software tool. | ||||||||||||||||
| Lark Health | Series C | $55 | Q4 | Kind River Capital, Franklin Templeton, SteelSky Ventures, Olive Tree Capital, Lightspeed Ventures, Asset Management Ventures and individual investors | The new funds will go towards expanding the company’s relationship with insurance companies and telehealth providers. | Lark has created an AI-based chronic disease management platform. | ||||||||||||||||
| Willow | Series C | $55.00 | Q3 | NEA, Meritech Capital Partners and Lightstone Ventures and Perceptive Advisors. | With the new funding, Willow says it will continue developing its breast pump technology to come out with new versions of its product. | To date, Willow has released three generations of its smart, in-bra breast pump. The latest iteration includes features that adjust the speed and rhythm of suction to match user preferences. | ||||||||||||||||
| Alan | Series C | $54.30 | Q2 | Temasek and Index Ventures | The company aims to launch additional services like these while expanding out of France into the rest of Europe. | Alan's health insurance platform looks to provide users with access to providers, information and other care support via its app. | ||||||||||||||||
| Ready | Unspecified | $54.00 | Q3 | GV, Deerfield Management Company, City Light Capital, Town Hall Ventures and Frist Cressey Ventures | The company said that it would be building out its operations and clinical programs with the new funds, and noted that its model will expand to include mental health, expanded point-of-care testing, vaccinations and more down the line. | Ready's approach sends nurses, paramedics or EMT "Responders" to a patient's home, where they deliver acute or longitudinal care with the support of clinicians via telehealth. | ||||||||||||||||
| Cityblock | Series B+ | $53.50 | Q3 | Kinnevik AB, AIMS Imprint of Goldman Sachs Asset Management, Alphabet and existing investors | The company plans to use the new funds to build out its services and technology for members. | Cityblock uses tech to tackle health disparities, improving access to primary care, behavioral health and social services. | ||||||||||||||||
| Caption Health | Series B | $53.00 | Q3 | DCVC, Atlantic Bridge, Edwards Lifesciences and Khosla Ventures | The company will be scaling its collaborations with research institutions, regional health systems and other providers. | Caption's software includes an AI to guide professionals through cardiac imaging procedures, and automatic ejection fraction calculation. | ||||||||||||||||
| Headspace | Series C | $53 | Q1 | blisce/, Waverly Capital, Times Bridge, The Chernin Group, Spectrum Equity and Advancit Capital | Headspace plans to continue growing its D2C, B2B and international offerings. | Headspace’s primary product is a free-to-download meditation app, but it also offers products for employer benefits programs. | ||||||||||||||||
| Modern Health | Series. C | $51 | Q4 | Battery Ventures, Kleiner Perkins, Founders Fund, 01 Advisors, Afore Capital, Okta cofounder Frederic Kerrest and Felicis Ventures | Modern said that it will be looking to add new offerings to its platform and expand its network of providers from 35 supported languages to more than 50. | Modern Health provides employers and their staff with a package of mental health benefits coordinated within an app. | ||||||||||||||||
| Olive | N/A | $51 | Q1 | General Catalyst, Drive Capital, Oak HC/FT, Ascension Ventures and other unnamed investors | Olive said that these funds will boost the AI company's growth, and "further its mission" of offloading the burden of administrative processes from hospital staff. | Olive's "AI Workforce" is designed to automate a selection of tedious, high-volume administrative tasks for healthcare organizations. | ||||||||||||||||
| Dascena Inc. | Series B | $50 | Q2 | Frazier Healthcare Partners, Longitude Capital, Euclidean Capital and another undisclosed investor. | The round will help Dascena continue development on its suite of diagnostic machine learning algorithms for clinician decision support. | The company's flagship product is a machine learning algorithm for sepsis. | ||||||||||||||||
| Ginger | Series D | $50.00 | Q3 | Advance Venture Partners, Bessemer Venture Partners, Cigna Ventures, Kaiser Permanente Ventures and LinkedIn Executive Chairman Jeff Weiner | Ginger did not outline specific plans for the money. | Founded a passive behavioral health monitoring platform, Ginger now delivers on-demand behavioral health services. | ||||||||||||||||
| Komodo Health | Series C | $50 | Q1 | Andreessen Horowitz, Oak HC/FT, IA Ventures and Felicis Ventures | Komodo is looking to expand its platform with the raise. | The company offers an analytics and insights platform for healthcare, life sciences and advocacy groups seeking a more detailed look into patient healthcare journeys | ||||||||||||||||
| PatientPop | Seriec C | $50.00 | Q3 | HLM Venture Partners, Commonfund, Vivo Capital, Toba Capital, Transformation Capital and Silicon Valley Bank | PatientPop says it will use these funds to continue to provide practices with the tools they need to give patients the care they need both in-person and online. | PatientPop's platform helps practices attract patients online through a customized website and search engine optimization | ||||||||||||||||
| Thread | "Strategic commitments" | $50.00 | Q3 | Water Street Healthcare Partners and JLL Partners | Thread will focus on expansion to more than 40 countries, development and implementation of COVID-19 clinical trial risk-mitigation tools, the introduction of new features for its platform, and the provision of worldwide and multilingual customer support. | Thread specializes in decentralized clinical research technology. | ||||||||||||||||
| Tyto Care | N/A | $50 | Q2 | Inight Partners, Olive Tree Ventures and Qualcomm Ventures | The company plans to use the new funds to expand its commercialization efforts the U.S., Europe and Asia. It is also looking at expanding its AI and machine learning home device product. | The company is part telehealth and part remote-monitoring. It allows patients to use digital tools to help conduct their exam at home, while being guided and evaluated by a doctor via telemedicine. | ||||||||||||||||
| K Health | Series C | $48 | Q1 | 14W, Mangrove Capital, Anthem, Lerer Hippeau, Primary Ventures and other unnamed backers | K Health will be expanding its product into new markets and refining the symptom checker tool. | K Health’s artificial intelligence questions users about their health issue and then shares how similar cases have been diagnosed and treated in the past. | ||||||||||||||||
| Headspace | Series C | $47.70 | Q2 | Undisclosed | While the company did not specify what the funding was for, the add-on funding would presumably be aiming for many of the same goals Headspace outlined near the beginning of the year. | Headspace is a mindfulness and meditation app. | ||||||||||||||||
| Thirty Madison | Series B | $47.00 | Q3 | Polaris Partners, Johnson & Johnson, Maveron and Northzone | The company plans to use this money to make chronic condition management easier and more enjoyable for patients. | Thirty Madison focuses on treating chronic health conditions through telemedicine. The company comprises three different brands, each targeting a different condition. | ||||||||||||||||
| Advantia | N/A | $45.00 | Q1 | BlueMountain Capital Management | This latest funding will enable the company to expand its practice with the goal of integrating OB-GYN, primary care, mental wellness and other health services. | The Arlington, VA-based startup provides women with medical care in a variety of physical locations, as well as through digital channels. | ||||||||||||||||
| Bigfoot Biomedical | Series C | $45 | Q1 | Abbott, Quadrant Capital Advisors, Senvest Capital, Janus Henderson and Cormorant Asset Management | The company said that these funds will support continued product development, FDA regulatory submission and clinical trials. | The Milpitas, California-based company is building an insulin delivery system able to connect to smartphones and other management devices. | ||||||||||||||||
| Evidation Health | Series D | $45.00 | Q3 | B Capital Group, McKesson Ventures, Section 32, Revelation Partners, Rethink Impact and SV Health Investors | The company will use its new funds to continue growing its study solutions business, as well as to kick off new programs for those participating in its app-based data collection efforts. | The San Mateo company combines real-life patient data collected through more than 100 different sources in order to assess care or specific interventions for payer, pharma, systems and device-maker customers. | ||||||||||||||||
| Intelycare | Series B | $45 | Q1 | Endeavour Vision, Kaiser Permanente Ventures and Generator Ventures | The company said it plans to use the new money to continue to build its gig economy platform and data science tech. | The company focuses on matching nurses and certified nursing assistants with acute healthcare facilities for certain shifts | ||||||||||||||||
| Maven | Series C | $45 | Q1 | Icon Ventures, Sequoia, Oak HC/FT, Spring Mountain Capital, Female Founders Fund, Harmony Partners and individual investors | Maven said the new money will be used to invest in its core digital offerings. | Maven currently offers digital health programs for women and children. It specializes in fertility, maternity, return-to-work and pediatric care. | ||||||||||||||||
| TigerConnect | Series D | $45 | Q4 | HealthQuest, New Leaf Ventures, Montreux Growth Partners, Norwest Venture Partners, Invus and Industry Ventures | The company said it will use the funds to expand product development and professional services to meet the growing demand for its system. | TigerConnect’s platform includes a suite of products designed to help hospitals and health systems organize their workflow and connect with patients. | ||||||||||||||||
| Well Health | Series C | $45 | Q4 | Lead Edge Capital, Martin Ventures, Jackson Square Ventures, Health Velocity Capital, Summation Health Ventures, Structure Capital and Freestyle Capital. | ell Health did not disclose what the funds would be used for. | Well Health operates a two-way communication hub for patients and healthcare organizations to connect throughout the entire care journey. | ||||||||||||||||
| Indigo Diabetes | Series B | $44.60 | Q3 | Fund+, Ackermans&van Haaren, Capricorn Digital Growth Fund, imec.xpand and Titan Baratto | The new funds are expected to push forward the development of the product and the next research phase. | The Gent-based startup is creating a continuous glucose monitoring sensor and corresponding app. | ||||||||||||||||
| 98point6 | Series D | $43 | Q2 | Undisclosed | The company said it will be tripling the size of its physician workforce before the end of the month to handle new demand. | 98point6 provides on-demand primary care services for consumers and health plans that can be accessed through the company's mobile app. | ||||||||||||||||
| Dialogue Technologies | Unspecified | $43.00 | Q3 | Sun Life, Caisse de dépôt et placement du Québec, Portag3 Ventures, White Star Capital, HV Holtzbrinck Ventures, First Ascent Ventures and Walter Ventures | The company did not specify how the funds would be used. | Dialogue is a telemedicine provider active within Canada. | ||||||||||||||||
| Owkin | Series A | $43 | Q2 | Mubadala Capital, Bprifrance, Cathay Innovation and MACSF | The company plans on using the new money to grow its technology. It will also go towards expanding its COVID-19 specific tool. | Owkin is a machine learning medical research company aiming to connect doctors, researchers, scientists and other stakeholders. | ||||||||||||||||
| K Health | Series D | $42 | Q4 | Valor Equity Partners, Marcy Venture Partners, Atreides Management, PICO Venture Partner, 14W and Max Ventures | The company highlighted a Mayo Clinic collaboration that it says will improve its algorithms. | The New York startup combines a symptom checker app with virtual primary care. | ||||||||||||||||
| LifeSpeak | Unspecified | $42.00 | Q3 | Round13 Growth Fund, Kensington Capital Partners and Roynat Capital. | The company said it would use the funds to expand access to LifeSpeak’s platform across health plans and employers. | LifeSpeak is the maker of an employee mental-health-and-wellness digital platform. | ||||||||||||||||
| BrightInsight | Series B | $40 | Q2 | Insight Partners headlined the raise, which also featured Series A investors New Leaf Venture Partners and Eclipse Ventures. | In addition to fueling the growth of its worldwide team, BrightInsight said it will be expanding its platform with more analytics functionalities and the launch of pre-built software assets for digital clinical trials. | BrightInsight – a part of electronics manufacturing services firm Flex – sees itself acting as the infrastructure of a digital health ecosystem. | ||||||||||||||||
| Elation Health | Series C | $40 | Q4 | Generation Investment Management, Threshold Ventures and Kapor Capital | Elation Health plans to further expand its core platform while adding on new capabilities, such as billing and payment collection. | Elation sells primary care practices software that helps digitize their business. | ||||||||||||||||
| Exo | Series B+ | $40.00 | Q3 | GlaxoSmithKline's Investor Action Potential Venture Capital fund | The company will be using the funds to wrap up product development for that device, and to bring its data and workflow apps to market. | Exo is best known for its handheld ultrasound device. | ||||||||||||||||
| Q Bio | Series B | $40 | Q1 | Andreessen Horowitz and Vinod Khosla | The company plans on investing the new funds into improving its tech and making it more affordable for a broader population. | The company conducts a full workup of patients based on biomarkers it deems relevant to determine patients' risk factors. | ||||||||||||||||
| Science 37 | Unspecified | $40 | Q3 | Lux Capital, Redmile Group, PPD, Inc., Novartis, Amgen, Sanofi Ventures, GV, Glynn Capital, LifeSci Ventures and Mubadala Ventures | The company said these new funds will help support growth of its platform and its international business. | Science 37 enables decentralized clinical trials with digital recruitment tools and BYOD support. | ||||||||||||||||
| Well Dot | Series A | $40 | Q4 | General Catalyst, John Doerr, Mosaic Health Solutions and Hellman & Friedman partners | The company is turning its focus inward to give more attention to its team and tech platform. | Well Dot is an AI startup that uses data and behavioral economics to provide daily health recommendations. | ||||||||||||||||
| Buoy Health | Series C | $37.50 | Q4 | Cigna, Humana, Optum Ventures, WR Hambrecht + Co., and Trustbridge Partners | With these funds the company will be fleshing out its AI and other tech features, improve its clinical and insurance navigation capabilities, and expand its workforce. | Buoy provides an AI triage and care navigation tool that takes the form of a patient-facing chatbot. | ||||||||||||||||
| Intuition Robotics | Series B | $36 | Q1 | SPARX Group, OurCrowd, Toyota AI Ventures, Sompo Holdings, iRobot, Union Tech Ventures, Happiness Capital, Samsung Next, Capital Point and Bloomberg Beta | The company said in its announcement that the raise would fund the continued development of its tech and AI capabilities. | Intuition Robotics’ AI efforts are split into two camps: digital assistants designed for use inside of a car, and a countertop companion robot for seniors called ElliQ. | ||||||||||||||||
| Abacus Insights | Series B | $35 | Q2 | Blue Venture Fund led the round, and was accompanied by CRV, .406 Ventures, Horizon Healthcare Services and Echo Health Ventures. | The Boston-based company will be deploying the new capital to scale its business, continue to flesh out the capabilities and connections supported by its platform, and make new hires. | Abacus Insights, a data interoperability technology company targeting health plan customers, collected $35 million in Series B funding, bringing its lifetime venture backing to $53 million. | ||||||||||||||||
| Cerebral | Series A | $35 | Q4 | Oak HC/FT, Westcap, Liquid 2 Ventures, Gaingels, Air Angels and other unnamed investors | The company plans to expand across the U.S. and pursue new partnerships with insurers. | Cerebral is a mental health membership service that offers clients telehealth visits with a provider and monthly chats with a care counselor. | ||||||||||||||||
| Whisper | Series B | $35 | Q4 | Quiet Capital, Sequoia Capital, FIrst Round Capital and IVP | Whisper did not disclose what the funding would be used for. | Whisper offers a hearing system composed of three components: the earpieces, a portable sound processor and a compatible mobile app. | ||||||||||||||||
| One Drop | Series C | $34.70 | Q3 | Bayer | The company will be working to expand its platform beyond diabetes and into other chronic conditions. | Oe Drop has developed a wireless blood glucose monitor system and self-management app. | ||||||||||||||||
| Centivo | Series B | $34 | Q4 | B Capital Group, Define Ventures, HarbourVest Partners, Nassau Street Ventures, Bain Capital Ventures, Company Ventures, F-Prime Capital, Ingleside Investors, Maverick Ventures and Rand Capital. | The company plans to use the new money to expand its offerings and scale its operation. | The insurtech company is focused on the self-funded employer market. | ||||||||||||||||
| Hazel Health | Series C | $33.50 | Q3 | Owl Ventures, Bain Capital Ventures, Uprising, Centene and UC San Francisco. | In the blog post announcement, the company said the funding would help Hazel "better serve our communities and provide preventative healthcare to more students," and highlighted insurance provider partnerships intended to increase access to the service. | Through partnerships with school districts, Hazel Health operates virtual care clinics inside the school nurse's office. | ||||||||||||||||
| Lemonaid Health | Series B | $33.00 | Q3 | Olive Tree Ventures, Artis Ventures, Correlation Ventures, Hikma Ventures, Sierra Ventures and other unnamed backers | Lemonaid will be using the new funds to increase the number of medical professionals under its roof, and to expand its offerings in asthma, hypertension, Type 2 diabetes and additional mental health care. | The San Francisco-based telehealth platform and provider originally focused on D2C telehealth, but recently has increased its work with healthcare systems. | ||||||||||||||||
| NeuroPace | Equity raise | $33.00 | Q3 | Accelmed Partners, Revelation Partners, Soleus Capital, KCK Group, OrbiMed Advisors and others. | Going forward, Neuropace said that it would be accelerating the company's commercial growth and exploring broader indications for its neurostimulation system. | NeuroPace's business is centered on its RNS System, an FDA-approved neurostimulator indicated for adults who experience frequent and disabling epileptic seizures from one or two sources within the brain, and who have tried two or more anti-seizure medications to no avail. | ||||||||||||||||
| Kindbody | Series B | $32.00 | Q3 | Perceptive Advisors, RRE, GV, Freemark Capital, Rock Springs Capital, Goodgrower, Claritas Capital and NFP | The startup will be using its new funding to expand its owned physical locations and network of partner clinics, both in the U.S. and internationally. | Kindbody is a women's health startup combining virtual care with face-to-face visits. | ||||||||||||||||
| Modern Health | Series B | $31.00 | Q1 | Founders Fund, John Doerr, Keliner Perkins and Afore Capital | The startup plans to use the new funds to accelerate product development and expand globally. | The San Francisco-based startup works with employer organizations to provide its members with a digital mental health platform. | ||||||||||||||||
| Big Health | Series B | $30.00 | Q2 | Gilde Health, Morningside Ventures, Samsung NEXT, Kaiser Permanente Ventures and Octopus Ventures. | The raise will support new product development, as well as growth of its distribution channels and commercialization efforts. | Big Health's two main products Sleepio and Daylight are digital programs to help users manage poor sleep and anxiety. | ||||||||||||||||
| HealthJoy | Series C | $30 | Q1 | Health Velocity Capital, US Venture Partners, Chicago Ventures, Epic Ventures and other individual investors. | The company will be looking to improve its existing AI tech, develop new services, make new hires and integrate with more business partners. | The core of HealthJoy's approach is Joy, a virtual assistant that helps users understand their benefits packages and navigate their care options through artificial intelligence-guided conversation. | ||||||||||||||||
| Higi | N/A | $30 | Q2 | Babylon Health, 7Wire Ventures, Flare Capital Partners, Jumpstart Capital, Rush University Medical Center for Health and William Wrigley Jr. | Higi will be using the funds to expand the reach and content offerings of its health kiosks, notably with the support of Babylon's tech. | Higi's distributes in-store health kiosks equipped to administer quick tests for blood pressure, pulse, weight and BMI. | ||||||||||||||||
| Kyruus | Series D | $30.00 | Q2 | Francisco Partners | Kyruus plans to use the new funds to expand its platform into new health systems and in new market segments. | The company makes a provider search and scheduling tool for health systems. | ||||||||||||||||
| Lumeon | Series D | $30.00 | Q3 | Optum Ventures, Endeavor Vision, LSP, MTIP, IPF Partners, Glide and Amadeus Capital Partners | Lumeon is looking to expand the reach of its platform with these funds. | Lumeon's primary offering is an EHR-integrated tool incorporating clinical and administrative data streams to guide and automate patient care. | ||||||||||||||||
| Medigate | Series B | $30.00 | Q3 | Partech, Maor Investments, YL Ventures, U.S. Venture Partners and Blumberg Capital. | Medigate kept its plans for the new funds vague, saying only that the money will help "expand Medigate's leadership and availability to healthcare organizations needing advanced protection, visibility and cost control." | Medigate's platform secures networked medical devices or Internet of things products that are connected to EHRs, device servers and other enterprise systems. It automatically identifies devices located in the network, classifies them by type and then analyzes their specialized protocols, communications and behaviors. | ||||||||||||||||
| Reify Health | Series B | $30.00 | Q3 | Battery Ventures, Sierra Ventures and Asset Management Ventures | The company will continue to expand its platform. | The startup's StudyTeam platform looks to speed up clinical trial enrollment and reduce workload burdens by handling redundant processes and highlighting data-driven insights. | ||||||||||||||||
| Vault Health | N/A | $30 | Q1 | Tiger Global Management, Redesign Health and Declaration Capital | According to its website, Vault has plans to expand its services across dozens of U.S. states and major population centers, including Chicago, Philadelphia, Boston, Los Angeles and Las Vegas. | Vault looks to improve mens' sexual, mental and wellness health with prescription hormone-replacement therapies and other health supplements. | ||||||||||||||||
| Your.MD | Series A | $30 | Q4 | Reckitt Benckiser | The new funds will go towards expanding the product in the U.K., India and U.S. markets. | The app platform helps patients make health decisions using symptom checkers, risk assessments and other health quizzes. | ||||||||||||||||
| Arcadia | N/A | $30 | Q1 | Cigna Ventures and existing shareholders | Arcadia did not disclose how it would be applying its new funds. | Arcadia develops a population health analytics technology platform for plans, providers, employers and life science groups. | ||||||||||||||||
| Carbon Health | Series B1 | $28 | Q2 | DCVC | The company said that it increased its staff from 100 employees to more than 300, and has now expanded its virtual-care service to treat patients in 15 additional states. | The San Francisco-based company runs a series of brick-and-mortar clinics in California. supported by the Carbon Health mobile app, through which patients can view their health records, schedule appointments, handle their payments or receive their care through a video telehealth visit. | ||||||||||||||||
| Oura | Series B | $28 | Q1 | Forerunner Ventures, Square and Google's Gradient Ventures | Oura's new funds will help the company acquire new staff members, revamp its branding and target new academic research partnerships. | The Oura Ring hosts a number of different sensors designed to monitor the wearer’s health while they sleep or engage in physical activities. | ||||||||||||||||
| Curai Health | Series B | $27.50 | Q4 | Morningside Ventures, General Catalyst and Khosla Ventures | The company plans to use the new money to expand its efforts and scale. | The company provides telemedicine primary care for a monthly subscription fee. | ||||||||||||||||
| Doctor Anywhere | Series B | $27 | Q1 | Square Peg, EDBI, IHH Healthcare, Pavilion Capital and Kamet Capital | The telehealth startup will use the funds for its extensive expansion to augment the region’s healthcare landscape through digital transformation, with the support of strong local and regional partners. | Doctor Anywhere is a video telehealth consultation service active in Southeast Asia. | ||||||||||||||||
| Solv | Series B+ | $27 | Q4 | Acrew Capital, MultiCare Health System, Light Street Capital, Benchmark and Greylock Partners | Solv plans to use the funds to expand its network of providers to give patients increased access to care, and will also grow its specialty areas. | Solv offers an online appointment-scheduling platform. | ||||||||||||||||
| SonderMind | Series B | $27 | Q2 | General Catalyst, F-Prime Capital, Kickstart Seed Fund, Diōko Ventures and Jonathan Bush | The new funds are expected to help the mental health startup expand its geographical footprint into Texas and Arizona, as well as ink deals with new payers, employers and health systems. | The Denver, Colorado-based company's platform helps link up patients and therapists based on specific needs and geographic location. | ||||||||||||||||
| Headway | Series A | $26 | Q4 | Thrive, GV, Accel, GFC and IA Ventures | The company will be working to expand its network of therapists and enter new regions. | The startup's free tool allows users to punch in their current health plan and search a network of therapists for a match, and then helps to handle booking, billing and other backend tasks. | ||||||||||||||||
| Nanox | N/A | $26 | Q1 | Foxconn, Fujifilm and SK Telecom | The current round will help Nanox develop, commercialize and deploy its Nanox System, the company said in its funding announcement. | Nanox has built a "digital X-ray" offering comprised on an in-hospital device and accompanying cloud software analysis tool. | ||||||||||||||||
| Nanox | N/A | $26 | Q2 | SK Telcom | This new investment comes with a partnership agreement between Nanox and SK Telcom. The two companies are working together to deploy 2,500 Nanox Systems into South Korea and Vietnam. | The company is currently working on a technology offering that combines an in-hospital scanning device with a companion cloud software tool. | ||||||||||||||||
| Bridge Connector | Series B | $25.50 | Q3 | Axioma Ventures and all other prior backers | The startup said that it would be using the funds to support its increasing market share and its new Destinations "integration-platform-as-a-service." | Bridge Connector is a vendor-agnostic healthcare interoperability startup. | ||||||||||||||||
| Eden Health | Series B | $25.00 | Q3 | Flare Capital Partners, Stone Point Capital, Greycroft, PJC, Max Ventures and Aspect Ventures | Eden did not specify its plans for the money. | Eden Health is a direct-to-employer healthcare provider that specializes in virtual primary care, insurance navigation and workplace pop-up clinics. | ||||||||||||||||
| Freeletics | Series B | $25.00 | Q3 | The round was led by JAZZ Venture Partners and Causeway Media Partners, with contributions from KKCG. | With this financial support, Freeletics plans to develop new technologies, expand into new markets – especially in the U.S. – and create new business verticals. | Founded in 2013, Freeletics uses AI technology to coach users through digital workouts and meal plans. | ||||||||||||||||
| Hydrow | N/A | $25.00 | Q2 | L Catterton, Rx3 Ventures and other prior backers | The company will be aiming to expand its workout content offerings, which include its mainstay rowing simulations, in addition to functional movement workouts. | Hydrow’s consumer device delivers an in-home rowing workout supported by live or on-demand digital courses. | ||||||||||||||||
| PicnicHealth | Series B | $25.00 | Q3 | The round was led by Felicis Ventures. | The company said that the new funds will be put towards new medical research that is based on real-world data that it captures from its users. | PicnicHealth is a startup that helps patients access and share their medical records. | ||||||||||||||||
| RapidAI | Series B | $25.00 | Q3 | The round was headed by Lennertz & Co. | The company said the raise would help advance its platform. | The company's platform uses AI to build high-quality CTs and MRIs, with the end goal of helping clinicians make faster and more accurate treatment decisions for patients with strokes or aneurysms. | ||||||||||||||||
| Truepill | Series B | $25.00 | Q3 | TI Platform Fund, Optum Ventures, Initialized Capital, Sound Ventures and other unnamed backers | The company said that it will be working to expand its product offerings; improve its integrated, direct-to-patient products; and meet increasing demand. | Truepill is a digital pharmacy that focuses on APIs, telehealth practitioners and pharmacy fulfillment services. | ||||||||||||||||
| Vida Health | Series A | $25 | Q2 | Ally Bridge Group, AME Cloud Ventures, Aspect Ventures, Canvas Ventures, NGP Capital, Webb Investment Network and Workday Ventures | The company will be using its funds to meet the growing demand for virtual care services – and in particular mental health care – triggered by COVID-19. | Vida's approach combines live health coaches and therapists with a data-driven mobile platform. | ||||||||||||||||
| Pager | N/A | $24.50 | Q1 | Health Catalyst Capital, Horizon BlueCross BlueShield of New Jersey, Goodwater Capital, Three Fields Capital, New Enterprise Associates and Lux Capital | Pager said that its raise would support new market expansion, new product launches and scaling of its platform and clinical operations in New York City and Raleigh, North Carolina. | Pager's platform seeks to guide users throughout the course of their care experience, from an initial in-app encounter with a live nurse, to scheduling appointments, to paying for those services. | ||||||||||||||||
| Tia | Series A | $24 | Q2 | Threshold Venture's Emily Melton, Define Ventures, ACME, Torch Capital, John Doerr, Homebrew and Compound | The company plans to use the new funds in order to build out its virtual health capabilities. | Tia follows a hybrid model of care – it offers both brick-and-mortar services and virtual tools to patients – that exclusively focuses on women's health. | ||||||||||||||||
| AristaMD | Series B | $24.00 | Q3 | Ascension Ventures and .406 Ventures | These investments will be used by AristaMD to grow its platform into new health systems across the U.S. | AristaMD developed an e-consult platform where PCPs can virtually connect with either specialists within their health system or those provided by AristaMD’s panel of board-certified specialists. | ||||||||||||||||
| Future | Series B | $24 | Q4 | Trustbridge Partners, Kleiner Perkins, Caffeinated Capital, and private investors and founders | The new funds are slated to go toward scaling the technology. | Future pitches a personalized, membership-based fitness service that employs a one-on-one coaching model | ||||||||||||||||
| Medici | Series B | $24 | Q2 | Barry Sternlicht, from Starwood Capital Group; Kenneth Griffin, from Citadel; Nathan Kirsh, from the Kirsh Group; Howard Jenkins, from Publix; and Tom Meredith, formerly of Dell | Medici offered slim details on how its new funds would be spent, other than to say that the money would help accelerate its growth both during and after the COVID-19 crisis. | Medici's mobile platform is a telehealth service bolstered by a range of messaging and billing features. | ||||||||||||||||
| Covera Health | Series B | $23.50 | Q1 | Insight Partners, Prism Ventures and other prior backers | The funds will allow the company to increase its data science R&D, particularly in its initial focus area of radiology. | Covera is a clinical data analytics company aiming to reduce medical misdiagnoses. | ||||||||||||||||
| Joint Academy | Series B | $23.00 | Q3 | Kinnevik, Karl-Johan Persson (H&M chairman) and Alfvén & Didrikso. | The Series B round will help the company accelerate in the US and expand its offering throughout Europe. | Joint Academy is a clinical evidence-based digital treatment for chronic joint pain, which connects patients with licensed physical therapists. | ||||||||||||||||
| PlushCare | Series B | $23.00 | Q2 | Transformation Capital led the round, which included GGV Capital, WTI and other unnamed individual investors. | The company said that the raise would help accelerate its development road map and fuel growth. | PlushCare's platform connects consumers across all 50 U.S. states to an online video visit with a doctor. | ||||||||||||||||
| Proscia | Series B | $23 | Q4 | Scale Venture Partners and Hitachi Ventures | Proscia plans to use the new money to build out its commercial efforts and global sales and marketing. It is also looking at expanding its technology, in particular its AI application portfolio. | The computational pathology startup uses AI to help labs, health systems and life science companies interpret tissue data. | ||||||||||||||||
| Nurx | Series C (closed in May) | $22.50 | Q3 | Trustbridge, Comcast Ventures, Wittington Ventures, Union Square Ventures and Kleiner Perkins Digital Growth Fund | Nurx said that the funds would help address growing demand for its offerings, and would support the introduction of new services for headaches and migraines. | Nurx made its name through telehealth prescription and delivery of birth control pills, but recently expanded its offerings to include other areas of reproductive health. | ||||||||||||||||
| Zipari | Series B | $22.50 | Q1 | Vertical Venture Partners, Health Velocity Capital, Healthworx and Horizon Healthcare Services | The startup plans to widen distribution channels, expand partner integrations, and scale the development of its product lines. | Zipari's technology platform seeks to engage consumers in their health insurance and improve patient experience. | ||||||||||||||||
| Holmusk | Series A | $22 | Q2 | Optum Ventures, Health Catalyst Capital, Heritas Capital and other individuals | The new funding round allows Holmusk to expand its US operations, and supports investment in its proprietary technology. | Holmusk's real-world evidence platform helps customers accelerate drug development and data-driven medcine. | ||||||||||||||||
| Nanit | N/A | $21 | Q2 | Jerusalem Venture Partners, Upfront Ventures, RRE Ventures and Rho Capital Partners | The company plans to use the new funds to expand its product line and global footprint. | Nanit specializes in tracking infants' sleep and breathing with a smart camera system and app. | ||||||||||||||||
| Oviva | Series B | $21 | Q1 | MTIP, Earlybird, AlbionVC, F-Prime Capital, Eight Roads Ventures and Partech | The new capital will be used to further develop Oviva’s technology and expand in Europe. | Oviva offers an evidence-based digital solution to stop the progression of and reverse Type 2 diabetes and obesity-related conditions. | ||||||||||||||||
| RapidSOS | N/A | $21.00 | Q2 | Transformation Capital, C5 Capital, Laerdal Million Lives Fund and existing investors | The company plans to use the money to extend the work it is currently doing. | The company developed its digital platform to provide free critical data to first responders in order to make faster and smarter emergency responses. | ||||||||||||||||
| Brightline | Series A | $20.00 | Q3 | Oak HC/FT, Blue Shield of California, Blue Cross Blue Shield of Massachusetts, Boston Children’s Hospital, SemperVirens VC, Rock Health and City Light Capital | Brightline is looking to improve its technology platform, and to build out its telehealth capabilities and the number of treatment programs. It will also be making new hires. | The startup formerly known as Emilio offers a virtual platform that connects children with behavioral health needs to live clinicians and clinical social workers. | ||||||||||||||||
| CyberMDX | N/A | $20 | Q2 | Sham (Relyens Group), Pitango Venture Capital and Qure Ventures | In addition to tech platform and research investments, the CyberMDX will be pushing its geographic expansion and go-to-market efforts with these new funds. | The company deploys healthcare cybersecurity software to a provider's network, where it identifies and protects the organization's connected medical devices, IT systems and other internet of things. devices. | ||||||||||||||||
| Deepcell | Series A | $20 | Q4 | Bow Capital and Andreesen Horowitz | The company plans to use the new funding to build out a cell morphology atlas and propel its efforts in cell classification and sorting. | Deepcell uses AI for cell classification and isolation for cell biology and translational research | ||||||||||||||||
| DrChrono | N/A | $20 | Q1 | ORIX Growth Capital | DrChrono said it would be reinvesting these funds into its tech platform, as well as in the growth of its engineering, sales and support capabilities. | The mobile-friendly EHR maker is known for its open platform featuring an API and app marketplace. | ||||||||||||||||
| Human API | Series C | $20 | Q4 | Samsung Ventures, CNO Financial Group, Allianz Life Ventures, Moneta VC, BlueRun Ventures, SCOR Life and Health Ventures, and Guardian Life Insurance Company | These funds will help continue to grow its business among insurance, pharma, and digital health clients, and help the platform enable new capabilities. | The startup offers a consumer-facing health data aggregation and sharing platform. | ||||||||||||||||
| NowRx | Series B | $20.00 | Q3 | Crowdfunding | The company will be establishing more of its "micro-fulfilment centers" to extend its areas of operation, as well as to accelerate the technology of its software platform. | NowRx combines proprietary pharmacy management software with last-mile logistics to provide a consumer app that simplifies orders and ensures prompt deliveries. | ||||||||||||||||
| Paige | Series B | $20.00 | Q3 | Goldman Sachs Merchant Banking Division and Healthcare Venture Partners | The new funds will be used to continue the growth of Paige's platform by working with biopharma companies to create diagnostic and clinical improvements to patient care. | Paige develops artificial intelligence tools to help oncologists and pathologists make faster decisions about caring for cancer patients. | ||||||||||||||||
| Sidecar Health | Unspecified | $20.00 | Q3 | Cathay Innovation, Comcast Ventures, Kauffman Fellows, GreatPoint Ventures, Morpheus Ventures and Anne Wojcicki | Sidecar Health will use these funds to push into new markets and expand its team. | Sidecar's app allows users to customize their annual coverage amount and options, and includes a price comparison tool for viewing different services from local providers. | ||||||||||||||||
| Suki | Series B | $20 | Q1 | Flare Capital Partners, Breyer Capital, Epsilon Health, First Round Capital and Venrock | The company plans to use the new funds to expand its partnerships, and build new AI capabilities and new features to "streamline documentation, coding, billing, and other administrative tasks." | The Redwood, CA-based startup pitches its AI-powered digital assistant as a way for providers to cut down on paperwork. | ||||||||||||||||
| WithMe Health | Series B | $20 | Q4 | OMERS Ventures, Oak HC/FT, Section 32, Shulman Ventures and MTS Ventures | The new funding will support further growth of its client base, as well as an extension of its medication guidance core offering. | WithMe Health is a personalized medication guidance company. | ||||||||||||||||
| Aetion | Series B | $19.00 | Q3 | Johnson & Johnson Innovation, JJDC, EDBI and Greenspring Associates | Aetion said that it would be working to expand the capabilities of its Aetion Evidence Platform and to further the company's push for worldwide standards in RWE. | Founded in 2013, the company's platform provides insights from RWE to decision-makers across life sciences, health insurance and provider organizations. | ||||||||||||||||
| Sofia | Series A | $19 | Q4 | Index Ventures | The funds will help the company further develop its product. | Sofía began with a telemedicine service that offered free medical video consultations and has since grown to include a technology-enabled health plan | ||||||||||||||||
| Ubie | Series B | $19 | Q2 | Suzuken | The startup will use the fresh funds to scale up the use of its healthtech platforms, expand research and development capabilities, and staff its various sales and engineering teams. | The Ubie for Hospital product is an AI-driven medical questionnaire software targeting users at medical institutions, in order to support document creation of clinical records under supervision from specialists. | ||||||||||||||||
| Springtide | Series A | $18.10 | Q4 | Deerfield Management Company and Optum Ventures | The company plans to use the funds to enhance its clinical operations as it expands into new markets, as well as to commercialize its technology platform for additional remote care options. | Springtide is a multi-site interdisciplinary practice with telehealth capabilities serving children with autism spectrum disorder and other developmental delays and disabilities. | ||||||||||||||||
| AristaMD | Series B | $18 | Q1 | Cigna Ventures, MemorialCare Innovation Fund, Avalon Ventures, CU Healthcare Innovation Fund and Stanford Health Care | The new infusion of cash is expected to help the company grow its services and products. | The startup focuses on giving primary care providers virtual consultations with specialists. | ||||||||||||||||
| Diameter | Series B | $18 | Q4 | Centene Corporation, Optum Ventures, LRVHealth, Connecticut Innovations and Activate Venture Partners. | The new funds will grow the company and expand its Fusion system's ability to synthesize and collect data. | Diameter focuses on synthesizing clinical data sets. It uses an API system to enable real-time data exchanges. | ||||||||||||||||
| Ezra | Series A | $18 | Q2 | FirstMark Capital, Accomplice, Seedcamp, Credo Ventures, Founders Future, LDV Capital, Jeff Raider, Dave Gilboa, Vlad Tenev, Fred Destin Andrei Dunca, Esther Dyson, Taavet Hinrikus, Daniel Dines, Dave McClure, and Jeremy Arditi | The New York tech company said that it aims to expand its collection of medical-imaging AI tools with the new funds. | Ezra is a medical imaging and AI startup targing cancer. | ||||||||||||||||
| Papa | Series B | $18.00 | Q3 | Comcast Ventures, Canaan, Initialized Capital, Sound Ventures, Pivotal Ventures with Magnify Ventures, Operator Partners and others. | Papa said in its funding announcement that the money would go toward growing its staff and supporting the aforementioned regional expansion. The company also plans to further build out its tech platform. | Papa's platform connects college and nursing students with seniors who might need help with tasks like transportation, grocery shopping, prescription pickups and technology comprehension – or those who are just in need of virtual or in-person companionship. | ||||||||||||||||
| RubiconMD | Series C | $18 | Q1 | Deerfield Management Company, Optum Ventures, HLM Venture Partners, Waterline Ventures and Heritage Provider Network | RubiconMD said in its announcement that these funds will help the company "leverage its data to deliver new product offerings to better serve primary care clinicians." | RubiconMD looks to deliver speedy access to asynchronous specialist consults for primary care practices and other provider customers. | ||||||||||||||||
| ConsejoSano | Series B | $17 | Q4 | Magnetic Ventures, The American Heart Association/Bernard J. Tyson Impact Fund, DaVita Venture Group, Salesforce Ventures, Victor Oladipo, 7wireVentures, Impact Engine, Tufts Health Plan, and Wanxiang America | The company did not specify a use for the funds, but highlighted the impact of COVID on its target populations. | The startup provides engagement tools designed to reach racial and ethnic minority patients. | ||||||||||||||||
| Health Scholars | Series B | $17 | Q1 | Arboretum Ventures, Venture Investors, Capital Midwest Fund, OSF HealthCare and other family office seed funders | The new funds will be put towards expanding the customer base of the product to the hospital and public safety market, and to build out its VR library. | The company uses VR to simulate a variety of clinical situations including operation, resuscitation and obstetric scenarios for educational purposes. | ||||||||||||||||
| Cyclica | Series B | $16.90 | Q2 | Drive Capital, Chiesi Farmaceutici, GreenSky Capital and members of Cyclica's management team | The new funds would support Cyclica's integrated proteome-wide drug-discovery platform, fuel expansion into adjacent sectors such as agrochemicals and broadly accelerate its commercial strategy. | Cyclica is an AI drug discovery platform. | ||||||||||||||||
| Bright.md | Series C | $17 | Q2 | B Capital, Seven Peaks Ventures, Concord Health Partners, Philips Health Technology Ventures and UnityPoint Health Ventures | The startup will be ramping up its technology offerings and increasing market expansion efforts with the new funds. | Bright.md's primary offering is SmartExam, which it describes as the "virtual front door" for patients seeking care. | ||||||||||||||||
| Koa Health | Series A | $16.50 | Q4 | Ancora Finance Group and Wellington Partners | Koa's plans for these funds include increased R&D and clinical trials for its various platforms. | Koa Health offers a handful of app-based digital platforms built for employer, provider and insurer customers. | ||||||||||||||||
| Nym Health | Series A | $16.50 | Q4 | GV, Bessemer Venture Partners, Dynamic Loop Capital, Lightspeed, Tiger Global, and angel investors | The funding will be put towards accelerating sales and marketing activities, as well as scaling product deployment and development. | Nym's tech enables “fully automated, efficient and transparent revenue cycle management” for healthcare providers. | ||||||||||||||||
| Lifesprk | Series A | $16 | Q2 | Virgo Investment Group | The funds will help Lifesprk invest in new technologies to support its Life Experience Alternative Delivery System (LEADS). | Lifesprk is a senior-care company that uses a prioprietary tech system to coordinate care. | ||||||||||||||||
| b.well Connected Health | Series A | $16 | Q1 | UnityPoint Health VEntures, ThedaCare and Well Ventures | The company didn’t specify exactly how the new funds would be used. | b.well aims to help curb patient information overload by bringing various health, financial and behavioral data points together. | ||||||||||||||||
| mPulse Mobile | Series C | $16.00 | Q3 | Optum Ventures, HLM Venture Partners, OCA Ventures, SJF Ventures, Echo Health Ventures and Rincon Ventures | The company will be expanding its conversational AI capabilities, enhancing its client engagement analytics platform and expanding its engagement tools. | The company uses AI to automate conversations between consumers and healthcare organizations. | ||||||||||||||||
| Qure.ai | N/A | $16 | Q1 | Sequoia India and MassMutual Ventures Southeast Asia | The fresh funds will be used for geographical expansion, product portfolio expansion and to support regulatory clearances. | The startup builds AI systems to assist doctors in reading X-rays and CT scans. | ||||||||||||||||
| Scopio Labs | Series B | $16 | Q2 | Olive Tree Venture, Aurum Ventures, OurCrowd, LR Group and others | Scopio is using the raise to further its manufacturing and sales efforts, as well as to further develop its clinical trial pipeline. | The Israeli company looks to automate imaging of full microscopy samples into digital scans, and offers a platform that includes remote-consultation support. | ||||||||||||||||
| SilverCloud | Series B | $16.00 | Q2 | MemorialCare Innovation Fund, LRVHealth, OSF Ventures and UnityPoint Health Ventures | The new money will go into growing SilverCloud and expanding its services. | The company works with provider organizations to deliver dozens of digital mental health programs. | ||||||||||||||||
| Sparta Science | Series B | $16 | Q1 | GSR Venture US, Arsenal Growth and existing investors | The funds will be put towards new engineering staff, research and the deployment of the tech into health systems and provider organizations. | Sparta Science uses data analytics to help users come up with an individualized plan in order to either reduce injury risk or improve their physical performance. | ||||||||||||||||
| optimize.health | Series A | $15.60 | Q3 | U.S. Venture Partners led the round, which also saw support from Foundry Group, Daher Capital, Openview Venture Partners, Bonfire Ventures and SOSV. | With the funds, optimize.health said it will be expanding its product and engineering teams, expands its sales and marketing operations, and tack new features and user experience improvements onto its platform. | The company launched with a focus on smart pill bottle caps, but recently pivoted to sell a remote patient-monitoring software platform that includes analysis tools for providers and engagement hooks for patients. | ||||||||||||||||
| Activ Surgical | Unspecified | $15.00 | Q3 | ARTIS Ventures, LRVHealth, DNS Capital, GreatPoint Ventures, Tao Capital Partners and Rising Tide VC | Activ Surgical plans to expand its ActivEdge platform in Europe and accelerate its commercialization in the U.S. | The company develops hardware-agnostic technology that uses computer vision and robotics to drive autonomous and collaborative surgical procedures. | ||||||||||||||||
| Augmedics | Series B | $15.00 | Q2 | Augmedics' US staff, AO Invest, Terralab Ventures and undisclosed investors | Augmedics plans to explore how it can integrate the xvision technology into other surgical applications. | The company develops augmented reality surgical image guidance tools. | ||||||||||||||||
| Cardiologs | Series A | $15 | Q1 | Alven, Bpifrance, ISAI, Kurma Diagnostics, Idinvest Partners and Paris Saclay Seed Fund | Cardiologs' product is capable of spotting 100-plus cardiac abnormalities from ECG recordings. | |||||||||||||||||
| Klara | Unspecified | $15 | Q3 | Google's Gradient Ventures, First Cressey Ventures, FirstMark Capital, Lerer Hippeau, Project A and Stage 2 Capital | These funds will be used for new hires and improvements to its offerings, including greater AI-based automation for patient intake and payments. | Klara has built a digital patient messaging and engagement platform. | ||||||||||||||||
| Meditopia | Series A | $15.00 | Q3 | Creandum and Highland Europe | The funds will be used to further its expansion and services. | Meditopia provides resources specifically designed to address cultural differences in the way topics such as sexuality are perceived around the world | ||||||||||||||||
| NexHealth | Series A | $15 | Q2 | Individual investors | NexHealth is aiming to grow its API offering with the new funds. | The startup offers an interoperable online healthcare appointment system with telehealth, messaging, payment processing and other features. | ||||||||||||||||
| Savana | Series B | $15 | Q4 | Cathay Innovation, Seaya Ventures and MACSF | Savana said that it will be growing its team to support its expansion in the U.S. | The company's AI software reviews doctors' clinical notes to identify and pull out data that could have an impact on the patient's care. | ||||||||||||||||
| ScriptDrop | Growth round | $15.00 | Q4 | Oio Innovation Fund, M25 and Rev1Ventures | The company said that is will be expanding its operations, expediting new partners and focusing on its engineering and operations. | ScriptDrop works with couriers to coordinate same-day delivery, offers pharmacies a direct integration with their system and engages patients through a consumer app. | ||||||||||||||||
| eVisit | Series A | $14 | Q4 | TVC Capital, Kickstart Seed Fund, University Growth FUnd and Jeremy Andrus | eVisit said the new funds will be put towards expanding its technology platform and scaling its operation. | The company provides a telehealth platform that includes several facets, including a scheduling, intake, waiting room management and discharge function. | ||||||||||||||||
| Genome Medical | Series B extension | $14.00 | Q3 | Samsung Catalyst Fund, Genome's founders, existing investors and others | The raise will help the startup accelerate development of the platform, first by expanding the patient-engagement and care-navigation platform for cancer, reproductive health and pharmacogenomics use cases. | Genome Medical offers patient-facing virtual visits and provider-facing consultations with genetic experts through its "telegenomics" platform. | ||||||||||||||||
| Inato | Series A | $14 | Q1 | Obvious Ventures, Cathay Innovation, Serena and Fly Ventures | The startup said that it is aiming to build out the predictive capabilities of its clinical trial platform. | Inato has developed a platform that helps biopharma clients select the optimal site for their clinical studies. | ||||||||||||||||
| Osso VR | Series A | $14.00 | Q3 | Kaiser Permanente Venture, SignalFire, GSR, Scrum Ventures, Leslie Ventures and OCA Ventures. | The company did not specify how it would be deploying the new fund.s. | Osso VR is a virtual reality platform for surgery training. | ||||||||||||||||
| RDMD | Series A | $14 | Q2 | Spark Capital, Lux Capital, Village Global, Garuda Ventures, Maveron Capital and a collection of angel investors | The company's plans include expansions into 20 more rare diseases.new research study launches for these conditions, collaborative partnerships and team hires. | RDMD employs personal health records to accelerate rare disease drug research. | ||||||||||||||||
| Wheel | Series A | $13.90 | Q1 | CRV, Tusk Venture Partners and Silverton Partners | Outside of supporting its launch, Wheel did not specify how the new funds would be used. | Wheel’s strategy is comprised of two major avenues: telehealth staffing opportunities for practitioners, and a scalable telehealth platform for companies. | ||||||||||||||||
| GYANT | Series A | $13.60 | Q3 | Wing Venture Capital, Intermountain Ventures, Grazia Equity, Alpana Ventures, Techstars Ventures and Plug and Play Ventures | GYANT said that the new funds will help further its tech platform and support greater interoperability for its customers. | GYANT's care-navigation business looks to serve as the "digital front door" for healthcare-provider organizations. The AI tool engages patients via chat to uncover their needs and direct them toward the services or tools they may need. | ||||||||||||||||
| Binah.ai | Series B | $13.50 | Q2 | Maverick Ventures Israel headlined the round, while prior backers Esplanade Ventures, Sompo International, GiTV and iAngels also participated. | The Tel Aviv, Israel-based company said that it's looking to boost its sales and marketing efforts with the new funds. | Its platform currently provides measurements of heart rate, heart rate variability, oxygen saturation and respiration rate, with plans in the works to add blood pressure, hemoglobin, temperature and more. | ||||||||||||||||
| Numan | Series A | $13.50 | Q4 | Novator, Anthemis Exponential, Vostok New Ventures, and Colle Capital | Numan is looking to invest in its tech while expanding its team and its operations. | Numan provides regulated treatment options for common male health concerns, with a team of clinicians who can create personalised treatment plans online. | ||||||||||||||||
| Quit Genius | Series A | $13.50 | Q1 | Octopus Ventures, Y Combinator, Startup Health and Triple Point Ventures | The company plans to use the funds to grow its product line and increase the scope of patients they treat. | The company is geared at treating individuals with tobacco-, opioid- and alcohol-use disorder through digital cognitive behavioral therapy programs. | ||||||||||||||||
| Cecelia Health | Series B | $13.00 | Q3 | Rittenhouse Ventures, Endo Investors, Boston Millennia Partners, SustainVC, G100 Capital and others | Cecelia will be using the funds to scale and accelerate market adoption of its virtual coaching and telemedicine services. | The company was initially founded as Fit4D, where it provided access to certified diabetes educators (CDE) for scalable one-on-one coaching. Its rebranding is focused on expanding into other chronic conditions. | ||||||||||||||||
| KēlaHealth | Series A (w/ grant money) | $12.90 | Q4 | Santé Ventures and Intuitive Ventures | The funds will be used to accelerate KēlaHealth’s expansion into more surgical centers across the U.S. | To prevent surgery complications, the platform uses machine learning and AI algorithms to assign patients a risk score and intervention recommendations. | ||||||||||||||||
| Medefer | Unspecified | $12.80 | Q3 | The round was led by Nickleby Capital. | The funds are primarily for growing the company. The startup plans to do this by investing in staff and tech services, as well as product development and contracts. | Medefer is split into three services: a healthcare provider, virtual outpatient pathway and a tech platform for doctors to conduct virtual visits. Currently the platform can deliver healthcare within the UK's NHS system. | ||||||||||||||||
| Noyo | Series A | $12.50 | Q3 | Costanoa Ventures and Spark Capital led the round with participation from Homebrew, Fika Ventures, Precursor Ventures, Core Innovation Capital, Garuda Ventures and Webb Investment Network. | The startup plans to use the funds in order to hire new staff members and expand its product line. It will also put the infusion of cash towards expanding partnerships with new insurers and benefits platforms, the company said. | The company is developing carrier-agnostic APIs that can communicate between different insurance and health organizations. | ||||||||||||||||
| Oxford VR | Series A | $12.20 | Q1 | Optum Ventures, Luminous Ventures. Existing backers Oxford Sciences Innovation, Oxford University Innovation and GT Healthcare Capital Partners | Oxford VR is set to accelerate its expansion in the US and grow its treatment pipeline. | Oxford VR looks at the potential of VR in creating automated psychological treatments. | ||||||||||||||||
| Castor | Series A | $12.00 | Q3 | Two Sigma Ventures, Hambrecht Ducera Growth Ventures and INKEF Capital | The funding will be used to make clinical research more patient-centric, create more meaningful data and address underserved communities. | Castor aims to simplify the research process through a platform that captures and integrates data from any source into one system. | ||||||||||||||||
| CloudCath | Series A | $12 | Q1 | Capital Integral, FundRx, The Capital Partnership, Coconut Tree Investments, Stanford University’s StartX Fund and other unnamed strategic and individual investors | The startup said in its announcement that its raise will support commercialization of its first product, as well as the development of more applications built on their remote monitoring tech. | CloudCath’s initial product is a connected device and monitoring software designed for end stage renal disease patients receiving peritoneal dialysis in their homes. | ||||||||||||||||
| Conversa Health | Series B | $12.00 | Q2 | Builders VC, Northwell Ventures, P5 Health Ventures, Nassau Street Ventures and UH Ventures | Conversa plans to use this additional funding to scale its communication platform. | The company makes an automated virtual care communication platform. | ||||||||||||||||
| Levels | Seed funding | $12 | Q4 | a16z and angel investors | The company did not specify plans for the funding, but notes that its system will be available for consumers next year. | Using continuous glucose monitoring and the smart software in the Levels app, people can get real-time analysis regarding how food, exercise and other lifestyle decisions are impacting their health. | ||||||||||||||||
| Particle Health | Series A | $12 | Q2 | Menlo Ventures, Collaborative Fund, Story Ventures, Company Ventures and individual backers | The company did not disclose its plans for the funds. | Particle Health offers digital health stakeholders such as telemedicine providers or pharmacies an API that securely and quickly pulls patient records. | ||||||||||||||||
| Unlearn.AI | Series A | $12 | Q2 | 8VC, DCVC, DCVC Bio and Mubadala Capital Ventures | The company is interested in growing its team. | Unlearn uses its machine learning model, called Digenesis, to construct digital twins for participants in clinical trials. | ||||||||||||||||
| Workit Health | Series B | $12 | Q4 | FirstMark Capital, Lux Capital, GingerBread Capital, Blue Cross and Blue Shield Venture Partners and actor Rob Lowe | The company did not outline specific plans for the new funds outside of general expansion. | The app-based platform connects patients to addiction medications like buprenorphine and naltrexone, as well as telemedicine therapy with a live provider. | ||||||||||||||||
| Oncomfort | Series A | $11.80 | Q3 | Debiopharm, Crédit Mutuel Innovation, Belgium's Walloon Region Regional Investment Company and others | The company will be looking to continue development of the platform, make new hires and accelerate its push into new European and American markets. | Oncomfort was founded in 2017, and launched its SedaKit for Digital Sedation product as an alternative to medications in June of last year. | ||||||||||||||||
| Siren | Series B | $11.80 | Q2 | Anathem Ventures, DCM, Khosla Ventures, 500 Startups and Peter Thiel’s Founders Fund | The company did not disclose its plans for the new funds. | The company has developed temperature-monitoring socks that can communicate with a software application. | ||||||||||||||||
| Upfront Healthcare | Series B | $11.50 | Q4 | Baird Capital, LRV Health, Echo Health Ventures, Nashville Capital Network and Hyde Park Venture Partners | The funds will be used to implement additional products and services to help address evolving patient and provider needs, accelerate the product roadmap, and expand sales and marketing. | Upfront is a healthcare communication and patient engagement platform. | ||||||||||||||||
| Navenio | Series A | $11 | Q2 | QBN Capital, G.K. Goh, Hostplus, Big Pi Ventures, Oxford Investment Consultants, Oxford Sciences Innovation (OSI), IP Group plc and the University of Oxford | The funds will be used to increase the scope of Navenio’s offering in the UK, as well as in the US and Asia, where it has a number of evolving partnerships. | Navenio provides infrastructure-free indoor location solutions to power a range of apps and platforms in sectors including healthcare. | ||||||||||||||||
| Bodyport | Series A | $11.20 | Q3 | Beehringer Ingelheim Venture Fund, Playground Global, Initialized Capital and other unnamed backers | Bodyport said that the raise will be used to "deepen key health partnerships," as well as to kick off a remote monitoring-based "virtual cardiac clinic." | Bodyport makes a connected bathroom scale for monitoring cardiac biomarkers. | ||||||||||||||||
| Siilo | Series A | $11.10 | Q3 | VC Heal Capital, Philips Health Technology Venture Fund and EQT Ventures | Siilo says it will continue to expand its product offering, increase network growth and make new hires. | Siilo provides a free messenger app for individuals and teams to coordinate patient care, expand their professional network, and reduce time making decisions by exchanging best practices. | ||||||||||||||||
| ClosedLoop.ai | Series A | $11 | Q4 | Greycroft, .406 Ventures, Silicon Valley Bank and Meridian Street Capital | The company did not specify its plans for the money. | ClosedLoop.ai is a data platform designed to help healthcare systems improve outcomes and cut costs. | ||||||||||||||||
| Qualio | Series A | $11.00 | Q3 | Storm Ventures, Sorensen Ventures, MHS Capital, Frontline Ventures and the founders of Flatiron Health and Plaid | The startup did not outline how the funds would be deployed. | Qualio's cloud-based platform looks to replace paper process-based quality management software with an easy-to-implement, easy-to-scale alternative. | ||||||||||||||||
| VIDA Diagnostics | Series C | $11 | Q2 | First Analysis Corporation, Blue Heron Capital, UnityPoint Health Ventures, Next Level Ventures, Chartline Capital Partners, the Rural Vitality Fund, Rittenhouse Ventures, Iowa First Capital Fund and the Angels' Forum | VIDA Diagnostics will be expanding the clinical portfolio of its platform. | The company offers an AI-powered lung imaging analysis platform called LungPrint. | ||||||||||||||||
| Boulder | Series A | $10.50 | Q1 | Tusk Ventures and Greycroft Partners | The latest funds will be invested in research, education and training more peer coaches. | The startup connects patients seeking treatment for opioid use disorder to teams of addiction specialist, care coordinators and peer coaches through a telemedicine platform. | ||||||||||||||||
| Infermedica | Series A | $10.25 | Q3 | European Bank for Reconstruction and Development, Heal Capital, Karma Ventures, Inovo Venture Partners and Dreamit Ventures. | This infusion of cash will support its R&D efforts, bolster its current features and support expansion to Germany and the U.S. | Infermedica's B2B-focused AI triage system includes a symptom checker, a call center triage feature and an API. | ||||||||||||||||
| Ribbon Health | Series A | $10.25 | Q1 | Andreessen Horowitz , Y Combinator and BoxGroup | The new funds will be put towards expanding the company’s tech and team. | Health Ribbon’s platform uses an API layer that integrates data on doctors, payers and costs for easier workflow. | ||||||||||||||||
| Bigfoot Biomedical | Series C add-on | $10 | Q2 | Pharma giant Abbott led the round with participation from Quadrant Capital Advisors Senvest Capital, Janus Henderson, Cormorant Asset Management and other funders. | The startup has developed an insulin-delivery system that is able to connect to smartphones and other management devices in order to help with dosing. | |||||||||||||||||
| Cloudbreak Health | N/A | $10 | Q1 | Columbia Partners Private Capital | The company said it plans to use the new funds to grow it sales team and build out its technology. | Cloudbreak Health combines telehealth and integrated language services aimed at helping patients with limited English proficiency or who are hard of hearing. | ||||||||||||||||
| Cohere Health | Series A | $10.00 | Q3 | Flare Capital Partners, Define Ventures and an unnamed "leading national strategic partner." | The company did not outline specific plans in its announcement. | Cohere Health's system places a focus on transparent care over siloed processes, and value-based agreements over fee-for-service. | ||||||||||||||||
| Cohere Health | Unspecified | $10 | Q4 | Flare Capital Partners and Define Ventures | Cohere Health said the funds will be used to further build up the CohereNext platform. | The CohereNext product aims to streamline prior authorization, automatically approving a full treatment plan while handling referrals and other downstream processes. | ||||||||||||||||
| Diligent Robotics | Series A | $10 | Q1 | DNX Ventures, True Ventures, Ubiquity Ventures, Next Coast Ventures, E14 Fund, Promus Ventures and Grit Ventures | The raise will help scale the product for a broader customer base. It's also continued support for the company's hardware and software development. | Diligent Robotics develops a robotic assistant for non-patient-facing hospital tasks. | ||||||||||||||||
| Freespira | Unspecified | $10.00 | Q4 | Lightspeed Venture Partners, Aphelion Capital, Medvest Capital and Freespira Chairman Russell Siegelman | Freespira hopes to speed up commercialization of its digital therapeutic. | Formerly Palo Alto Health Sciences, the company's FDA-cleared digital therapeutic is intended to reduce or eliminate panic attack symptoms after 28 days of use. | ||||||||||||||||
| Helium Health | Series A | $10.00 | Q2 | Global Ventures, Africa Healthcare Masterfund, Tencent, Ohara Pharmaceutical, HOF Capital, Y Combinator, VentureSouq, Chrysalis Capital, Kairos Angels and Flying Doctors Healthcare Investment Company | The startup will use the funding round to grow its current customer base in Nigeria, Ghana and Liberia, as well as to support expansion into new markets in North and East Africa, and French West Africa this year. | Helium Health is a telehealth and healthcare technology provider in West Africa. | ||||||||||||||||
| JAXJOX | Series A | $10 | Q4 | Dowgate Capital and Nigel Wray | JAXJOX's new funds will help the company prepare for launch and global retail expansion, and will also support R&D. | The company's home gym will include a collection of free weights with performance-tracking capabilities, and will be paired with live coaching. | ||||||||||||||||
| Movano | Bridge funding | $10.00 | Q3 | Tri-Valley Ventures | Movano said in its announcement that its newest funds will help finalize production silicon and kick-start preparations for initial user trials. | Movano is developing a connected CGM wearable that doesn't require the user to break the skin with a needle or prick | ||||||||||||||||
| Okadoc | Series A | $10 | Q1 | Abu Dhabi Investment Office, Ithmar Capital Partners and other institutional and private investors | The new funding would drive its expansion into Saudi Arabia and other member countries of the Gulf Cooperation Council. | Okadoc makes a doctor booking platform with telemedicine components. | ||||||||||||||||
| Sprout | Seed funding | $10.00 | Q3 | General Catalyst, Bling Capital and Felicis Ventures | Sprout did not outline specific plans for its seed funding in the announcement. | Sprout is an autism care and treatment program combining in-home assessments with a tech platform. | ||||||||||||||||
| Togetherall | Strategic investment | $10 | Q4 | FPE Capital LLP | The company will continue its growth among the U.K. and Canadian schools, businesses and health organizations it serves, and will also be making a push into the U.S. | The online service provides clinically managed online communities where specific populations can anonymously support their peers' mental health. | ||||||||||||||||
| Ultromics | Series A | $10.00 | Q2 | Oxford Sciences Innovation and Mayo Clinic. | The company said this new infusion of cash will go towards growing its next stage of business growth. | It is currently focused on creating decision-support tools for the heart health space. | ||||||||||||||||
| Unmind | Series A | $10 | Q1 | Project A and Felix Capital | The new infusion of cash is set to help the company expand its global footprint. | Unmind provides mental health assessments to help employees track their mental health over a period of time. | ||||||||||||||||
| Voiceitt | Series A (closed June 30) | $10.00 | Q3 | Viking Maccabee Ventures, Microsoft's M12, AMIT Technion, Cahn Capital Corp, Connecticut Innovations, AARP, Quake Capital, SLJ Family Office, Dreamit Ventures and The Disability Opportunity Fund | The company did not outline its plans for the money. | Voiceitt’s application enables people with severe speech impairments to communicate by voice and translates unintelligible and atypical speech in real time. | ||||||||||||||||
| Wellth | Series A | $10 | Q2 | Yabeo, Boehringer Ingelheim Venture Fund, AXA Venture Partners, New York Life Ventures, NFP Ventures, I2BF Global Ventures, the Partnership Fund for New York City, Rock Health, DaVita Venture Group | The company said that it will be using the funds to scale its platform so that it can support more substantial patient populations. | Wellth's mobile platform uses behavioral economics to encourage treatment adherence for payers or employers. | ||||||||||||||||
| Braid Health | Seed and Series A | $9 | Q2 | Lux Capital, 01 Advisors and Rucker Park Capital | It plans to use the new funds to hire new team members, continue to build an AI-powered diagnostic platform, and develop a platform that can connect to networks of healthcare providers. | The company has created a teleradiology platform that combines AI technologies and board-certified radiologists. | ||||||||||||||||
| Ferrum Health | Seed round | $9 | Q2 | Blumberg Capital, GSR, Vulcan Capital, Valley Capital Partners and "an undisclosed strategic family office" | The new funds will help the startup continue to flesh out its technology, pick up new engineering hires, and expand its sales and marketing efforts. | Ferrum is building an artificial intelligence platform that aims to spot and prevent medical errors and spot potential cancer diagnoses within the hospital's radiology department. | ||||||||||||||||
| Limbix | Series A | $9 | Q2 | GSR Ventures, Sequoia Capital, Storm Ventures, NexGen Venture Partners and BIXINK Therapeutics | The new money will go towards developing Limbix's product and testing it. | The company is focused on creating a digital mental health tool for teens, and works through a mobile app. | ||||||||||||||||
| Orbita | Series A | $9 | Q2 | Philips Health Technology Ventures, HealthX Ventures, Cultivation Capital and Newark Venture Partners | The company did not specify how it would use the funds. | Orbita's technology platform is employed by healthcare, life sciences and medical technology companies seeking conversational AI capabilities that can be deployed through online, phone, text or digital-assistant means. | ||||||||||||||||
| Siren | Series B | $9.00 | Q3 | Manta Ray, Mighty Capital, David Helgason, Anathem Ventures, Khosla Ventures, DCM and Founders Fund | The company said that it has been, and continues to, grow its team to meet the higher demand for its product. | Taking the form of smart socks, the garments connect to a broader software application that allows a podiatrist to look out for inflammation or other risks that presage diabetic foot ulcers. | ||||||||||||||||
| StuffThatWorks | Seed funding | $9.00 | Q3 | Bessemer Venture Partners, 83North and Ofek Ventures | The company did not disclose its plans for the funds. | StuffThatWorks is a community platform that uses AI to encourage patients to share their treatment experiences. | ||||||||||||||||
| Sword Health | Series A (phase two) | $9 | Q1 | Khosla Ventures, Founders Fund, Green Innovations, Lachy Groom, Vesalius Biocapital and Faber Ventures | The company plans to put the new funds toward distribution, partnerships, sales and marketing. It also plans strategic product, clinical and operational investments. | Sword works with insurers, health systems and self-insured employers to provide tech-enabled physical therapy to its members, with a focus on musculoskeletal disorders. | ||||||||||||||||
| Mindler | Series A | $9 | Q2 | Ventech and Schibsted Growth | Mindler plans to use the money to support the development of the platform and open it up to other European markets. | The startup aims to make psychological help available to whomsoever may require it through its free smartphone app for video CBT. | ||||||||||||||||
| Endofotonics | N/A | $9 | Q2 | Tony Tan Choon Keat and Dr. Beng Teck Liang | The funds will be used to drive commercialization of its early gastric cancer detection system, SPECTRA IMDx, in Asia Pacific and to expand the coverage of its cancer detection technology to other organs. | Endofotonics' SPECTRA IMDx system enables real time detection of early gastric cancer during endoscopy, in part with the support of proprietary AI. | ||||||||||||||||
| Rivet Health | Series A | $8.25 | Q1 | Menlo Ventures, Lux Capital and Pelion Venture Partners | The startup said that these new funds will help grow its workforce, strengthen the platform's cost-transparency capabilities and solidify its role as an end-to-end patient billing suite. | Rivet's technology platform helps providers give their patients a pricing estimate prior to their services, as well as the option to pay beforehand or shortly after receiving care. | ||||||||||||||||
| Heartbeat Health | Series A | $8.20 | Q1 | .406 Ventures, Optum Ventures, Kindred Ventures, Lerer Hippeau, Designer Fund and Max Ventures | The new money is expected to increase the company's national footprint. int. | The company is focused on using digital tools to aggregate heart data and provide care management to patients. | ||||||||||||||||
| Meru Health | Series A | $8 | Q2 | Foundry Group, Slack, Bold Capital and Y Combinator | While the company did not specify exactly how the funds will be used, it has been stressing its commitment to furthering research on its product and digital mental health. | Meru Health offers several different mental health services, including a 12-week tailored content program. | ||||||||||||||||
| Big Sky Health | Series A | $8 | Q2 | Greycroft | The new funds will propel the launch of the Zero Plus, the company's new alcohol reduction platform. | Big Sky Health's main product is focused on helping dieters with their fasting regiment. The app includes a fast timer, as well as a digital journal and statistics. | ||||||||||||||||
| NovaSight | Series A | $8.00 | Q3 | Rimonci Capital and other strategic investors | The funds will support a pivotal study and assist with future development. | NovaSight's lead product is a device treatment for myopia, or lazy eye. | ||||||||||||||||
| Podimetrics | Series B-2 | $8.00 | Q3 | Polaris Partners, Rock Health, Norwich Ventures and Scientific Health Development | The funds will support a pivotal study and assist with future development. | Podimetrics makes a connected platform for diabetic foot-ulcer detection, consisting of a cellular-connected SmartMat for use in the home and a corresponding clinician-facing dashboard. | ||||||||||||||||
| Air Doctor | Series A | $7.80 | Q1 | Kamet Ventures and The Phoenix Insurance Company | The new investment will be used to bolster Air Doctor’s medical network, R&D capabilities and for international expansion across the insurance, telecom, and credit card industries. | Air Doctor connects travellers who fall sick abroad with local private physicians who are skilled at treating non-emergency conditions. | ||||||||||||||||
| K4Connect | Series B extension | $7.70 | Q3 | Forte Ventures | The company said that its new funds will speed up the development and deployment of new connected technologies for older adults. | K4Connect offers senior and disability technology to continuing care, independent living and assisted living communities. | ||||||||||||||||
| Zeto | Series A | $7.30 | Q1 | Seraph Group, Aphelion Capital, SV Tech Ventures, and Shangbay Capital | The new money will go towards accelerating the commercialization of the zEEG. | Zeo's zEEG headset is able to perform an EEG reading and then transfer those results onto a provider’s laptop, phone or tablet via the cloud. | ||||||||||||||||
| Avive Solutions | N/A | $7 | Q2 | Laerdal Million Lives Fund, Kenko Venture Partners, Irish Angels and other individual investors with healthcare experience | The new funds will help prepare Avive for its commercial launch. | The company develops technologies that integrate with emergency response systems to quickly help those experiencing out-of-hospital sudden cardiac arrest. | ||||||||||||||||
| Datos Health | Series A | $7 | Q2 | Crescendo Venture Partners, Industry Ventures, Vertex and Angular Ventures | Datos said that it would be looking to expand its sales and marketing efforts with the new funds. The company is also aiming to beef up its workforce and accelerate development of its workflow-friendly remote-care platform. | Datos offers an automated remote care and telemedicine platform for hospitals. | ||||||||||||||||
| FraudScope | Series A | $7.00 | Q3 | QED Investors, Brewer Lane Ventures, the GRA Venture Fund, Spider Capital, Mosley Ventures and TechSquare Labs | FraudScope plans to use the capital to scale its team and expand product offerings. | FraudScope provides health systems a workflow tool that can detect and investigate fraud, waste and abuse schemes using AI technology. | ||||||||||||||||
| Lionrock Recovery | N/A | $7.00 | Q2 | Wasserstein Family Trust and Big Spruce Holdings | With this raise, the startup aims to further build out its staff, marketing efforts, clinical offerings and proprietary-practice management systems. | Lionrock Recovery is a telehealth services provider specializing in substance-use disorders. | ||||||||||||||||
| Navina | Seed funding | $7 | Q4 | Grove Ventures | Navina's platform will receive further R&D support as a result of the funds. | The company's tool builds "patient portraits" that reorganize disparate patient data for easier clinician review. | ||||||||||||||||
| XRHealth | N/A | $7 | Q2 | Bridges Israel, Flint Capital and 20/20 HealthCare Partners | The new funds would help expand the new telehealth platform so that it can reach more clinicians and patients during the COVID-19 crisis. | The startup (formerly VRHealth) has developed a number of health applications for its VR platform, and more recently has dipped into remote care. | ||||||||||||||||
| Lucine | Unspecified | $6.60 | Q4 | Kurma Partners, Bpifrance's Autonomous Patient Fund, BNP Paribas Développement, Aquiti Gestion and Irdi Soridec | Lucine said it will be putting together new clinical studies for its digital therapeutic product. | The company's app uses face recognition and AI to quantify the user's pain and deliver personalized treatments such as cognitive behavioral therapy. | ||||||||||||||||
| Neurovalens | Unspecified | $6.56 | Q3 | IQ Capital, Wharton Asset Management Company, The Angel CoFund (ACF), Techstart Ventures, Clarendon Fund Managers and the Government’s Future Fund | The funding will be used for clinical trial research and development in the UK and abroad, as well as hiring additional staff. | Neurovalens’ technology aims to influence the brainstem and hypothalamus in a non-invasive way to cure or treat neurological diseases, without the need for implanted electrodes. | ||||||||||||||||
| Medloop | N/A | $6.50 | Q1 | Kamet Ventures and AXA | The investment will be used to leverage the current infrastructure of Medloop and expand its product offering to help doctors deliver preventative care in Germany and the UK. | Medloop is an integrated patient management tool that offers doctors a browser-based dashboard to manage their patient base, and a native mobile application for patients to access care services. | ||||||||||||||||
| Nucleai | Series A | $6.50 | Q3 | Debiopharm | The Israeli startup plans to continue development on its platform and expand commercial reach to potential pharma and biotech business partners. | Nucleai develops an AI platform for precision oncology research and treatment decision-making. | ||||||||||||||||
| Ride Health | Seed funding | $6.20 | Q1 | Activate Venture Partners, New York Ventures, Newark Venture Partners, BioAdvance and Startup Health | The startup’s announcement was light on specifics, saying only that the funding will “support Ride Health’s mission." | Ride Health offers a real-time, web and mobile NEMT platform for health plan and healthcare provider partners. | ||||||||||||||||
| PatientPay | N/A | $6.15 | Q1 | Mosaik Partners | The company plans to use the new funds to grow its product line and expand its services. | The company focuses on billing services regarding acute, ambulatory and specialty care. | ||||||||||||||||
| Prospection | N/A | $6.15 | Q1 | Main Sequence Ventures' CSIRO Innovation Fund and Horizons Ventures | The funds will be used to accelerate the company’s healthcare analytics platforms into new therapy areas, grow its artificial intelligence capabilities, and expand into Asia Pacific. | The company uses predictive analytics and machine learning, with real-world healthcare data, to unearth insights that improve patient outcomes. | ||||||||||||||||
| Aktia | Series A | $6.10 | Q1 | Redalpline, Translink Capital, Investiere, Libra, Christian Wenger, Spark Street Capital and Barbaric Holdings | The company said the new funds will help it bring the product to market. Currently, the strategy is to bring the tech directly to the end user. | The company has built a continuous-blood-pressure-monitoring bracelet that is equipped with an optical sensor and a software algorithm that measures an individual's blood pressure. | ||||||||||||||||
| Cariloop | Series A | $6 | Q2 | Patterson Thoma Family Office, Revolution's Rise of the Rest Seed Fund, ACAP Health, KCRise Fund, MPK Equity Partners, Patrick McGee and other unnamed existing backers | The new funds will help expand Cariloop's team and accelerate its nationwide strategic distribution efforts. | Cariloop is a a tech platform that focuses on coaching and cloud-based support tools for caregivers. | ||||||||||||||||
| Curve Health | Seed funding | $6 | Q4 | Lightspeed Venture Partners | The company is fleshing out the platform's user experience and pursuing an "aggressive market expansion plan." | Curve's platform is a blend of telehealth, smart billing, predictive analytics and a health information exchange. | ||||||||||||||||
| HelpAround | N/A | $6 | Q1 | IQVIA, Windham Ventures and other unnamed participants | This new investment will be put towards growing HelpAround's data science services in order to help patients find specialty therapies and clinical trials. | The Israeli startup's platform works with healthcare stakeholders, namely drug manufacturers, to acquire and onboard new patients. | ||||||||||||||||
| Immertec | Series A extension | $6.00 | Q3 | Revolution's Rise of the Rest Seed Fund, Benvolio Group and PAR | These new funds will help expand into new areas and hire new staff, among which would be a COO. | Immertec offers virtual reality surgical training technology. | ||||||||||||||||
| SteadyMD | Series A | $6 | Q2 | Pelion Venture Partners, Next Ventures, First Trust Capital Partners, the Daube Family Office, Crosscut Ventures, M25, Wild Ventures and Hyde Park Venture Partners | These funds will further develop SteadMD's technology platform and online services. | The startup's virtual care service connects members to text, phone and video care from board-certified primary care, pediatrics and functional-medicine doctors. | ||||||||||||||||
| Yes Health | N/A | $6 | Q2 | Khosla Ventures | The company said it will be expanding its staff, fleshing out its platform and scaling its business. | Yess Health's chronic disease management platform uses AI to support human coaches. | ||||||||||||||||
| Perfood | Series A | $5.90 | Q4 | Boehringer Ingelheim Venture Fund, UV-Cap and investiere | Perfood plans to launch its digital therapeutic for migraine treatment and advance its pipeline. | Perfood is a German startup combining digital therapeutics with personal nutrition. | ||||||||||||||||
| uMotif | Series A | $5.86 | Q3 | The round was led by existing investor AlbionVC. | The funding will accelerate uMotif’s growth and enable further development of its patient-centric and decentralised approach to clinical studies and enable expansion into new study types and more high-demand territories. | uMotif is a UK-based data capture software company. | ||||||||||||||||
| TestCard | Bridge funding round | $5.80 | Q4 | West Hill | TestCard plans to double its staff and bridge the business until an eventual Series A in 2021. | TestCard is known for its mobile-enabled platform for at-home urine testing. | ||||||||||||||||
| Vivante Health | Series A1 | $5.80 | Q1 | Lifeforce Capital, Big Pi Ventures, NFP Ventures, FCA Venture Partners and Longmont Capital | The new funds will speed up Vivante's efforts on GIThrive, its digital digestive health program. | Vivante’s GIThrive is a digital digestive health program that includes an at-home microbiome testing kit, a breath-based food sensitivity monitor and other support tools. | ||||||||||||||||
| TimeDoc | Series A | $5.70 | Q2 | Vocap Investment Partners, Grand Ventures, Serra Ventures, Waterline Ventures, Impact Engine, Break Trail Ventures, Chaifetz Group and Pat Welsh | The new cash will help the company increase its sales capabilities, deepen its integration with EHRs, enable remote patient-monitoring features and build new tools to improve patient outcomes. | TimeDoc offers a chronic care population management platform. | ||||||||||||||||
| Dorsata | Series A | $5 | Q2 | Women’s Health USA, QED Investors, LabCorp, Fool Ventures and Gore Range Capital | Dorsata offers a tool designed to help prevent variations in medical care during maternity and decrease the rate of preventable complications. | The company plans to use the new funds to integrate Dorsata into new EHR systems and bring the system to new providers and patients. | ||||||||||||||||
| Retina-AI Health | Series A | $5.20 | Q3 | Bill Smith | The company is pushing its product through FDA regulatory approval. | The company is developing screening software for diabetic retinopathy detection. | ||||||||||||||||
| Skin Analytics | Series A | $5.20 | Q3 | Hoxton Ventures led the raise, which also saw participation from Nesta and Mustard Seed Ventures. | With the money in hand, the company said it's looking to strike new deals with the U.K.'s NHS. Following up on a Breakthrough Device Designation from the FDA, it also is looking to expand its business into the U.S. | Skin Analytics is a U.K. startup building an AI-based early detection tool for skin cancer. | ||||||||||||||||
| Calibrate | seed | $5 | Q2 | led by Forerunner Ventures. | To launch the digital-weight-management startup | Calibrate is a one-year telemedicine program focused on weight loss that combines both prescription medications and health coaching. | ||||||||||||||||
| Twentyeight Health | Seed funding | $5.10 | Q4 | Third Prime, Town Hall Ventures, SteelSky Ventures, Aglaé Ventures, GingerBread Capital, Rucker Park Capital, Predictive VC and angel investors | To launch the digital-weight-management startup. | Twentyeight Health provides women's health and contraception prescriptions via telehealth. | ||||||||||||||||
| careMESH | seed | $5 | Q2 | Assurance Capital and Pavey Family Investments. Prior backers in the company also participated. | The Virginia startup said that it would be using the raise to increase adoption of its platform. | It is the maker of a national provider directory and information sharing platform. | ||||||||||||||||
| Gento | Series A | $5 | Q1 | Palisades Growth Capital | The startup said that these funds will support nationwide expansion of its technology platform. | Through its app-based platform, Gento matches care professionals with post-acute care providers such as home health agencies and skilled nursing facilities. | ||||||||||||||||
| HealthMetrics | Series A | $5 | Q4 | ACA Investments | HealthMetrics will be expanding its regional footprint across Southeast Asia, and pushing further into telemedicine, digital wellness and preventive programs. | HealthMetrics connects companies to its partner healthcare providers while giving both parties access to accurate benchmarking and data analytics reporting. | ||||||||||||||||
| Nice Healthcare | Seed funding | $5 | Q4 | Waterline Ventures, Conductive Ventures and INdie.vc | The company said that it's expanding its reach, and will be adding virtual physical therapy. | Offered through employers, Nice Healthcare's business uses a patient mobile app to schedule primary care virtual visits. | ||||||||||||||||
| Noteworth | Seed funding | $5.00 | Q3 | The startup said that it will be using its new funds to build out its operations, make new strategic hires and further support the Noteworth platform. | The company's software supports care through data collection and management, patient engagement and remote patient-monitoring. | |||||||||||||||||
| Paige | Series B add-on | $5 | Q2 | Goldman Sachs | Paige plans to put the new money towards growing its diagnostic and testing products. | The company uses artificial intelligence to help oncologists and pathologists make faster decisions about how to care for cancer patients. | ||||||||||||||||
| ResApp | N/A | $5 | Q1 | Unnamed investors | The funds raised will be used to accelerate European commercialization and for general working capital. | ResApp creates smartphone apps for the diagnosis and management of respiratory diseases. | ||||||||||||||||
| Trellus Health | Seed funding | $5 | Q3 | Mount Sinai Health System and EKF Diagnostics | The company did not specify an immediate goal for its new funds. | Trellus offers a connected care platform for treatment of chronic diseases such as inflammatory bowel disease | ||||||||||||||||
| uMed | Seed round | $4.80 | Q4 | AlbionVC, Delin Ventures, Playfair Capital and 11.2 Capital | The company did not specify plans for the money. | uMed’s platform automates the clinical study process, creating regulatory quality patient registries that combine electronic health data with structured data captured from each patient. | ||||||||||||||||
| Outcomes4Me | Unspecified (w/ grant funding) | $4.70 | Q4 | Asset Management Ventures, Sierra Ventures, Merstal Ltd. and other unnamed backers | With these funds, the company said that it will be looking to new types of cancers. | The free mobile app gives patients resources about their condition and helps them organize their personal information. | ||||||||||||||||
| BestDoctor | Unspecified | $4.50 | Q3 | AddVenture, Target Global, LVL1 fund | The company did not specify how the funds would be used. | The company offers virtual health consultations and access to mental health therapists 24/7 for employer customers. | ||||||||||||||||
| Homedoctor | Series A | $4.50 | Q4 | Cogito Capital Partners and other prior investors | HomeDoctor is eyeing expansion into new countries as wells as new regulatory inroads. | The company offers both virtual telemedicine visits and the option to digitally book a home visit. | ||||||||||||||||
| MedArrive | Seed funding | $5 | Q4 | Kleiner Perkins and Define Ventures | The company said that it plans to keep building out its tech platform, expand its team and target partnerships that will help push beyond its initial focus on the Florida market. | The startup employs and coordinates EMS providers who are deployed to the home of a patient with the support of virtual tech. | ||||||||||||||||
| Folx | Seed funding | $4.40 | Q4 | Define Ventures, Bessemer Venture Partners and Polaris Partners | The company will be directing its new funds toward developing more treatment offerings, expanding its clinical network and entering new states. | Folx is a consumer-facing virtual health services program designed for the U.S. LGBTQIA+ population. | ||||||||||||||||
| Babyscripts | Unspecified | $4 | Q4 | Banner Health, WellSpan Health the Froedtert & the Medical College of Wisconsin regional health network and University of Colorado's CU Healthcare Innovation Fund. | By partnering with its customers for the new investment, Babyscripts said that it is looking to incorporate their input and continue developing its product to meet their needs. | The company's platform gives providers a better look at maternity patients through a dashboard and data collected from connected devices and apps. | ||||||||||||||||
| Lucid Lane | Seed funding | $4 | Q2 | Battery Ventures | The company did not outline specific plans for its seed funding. | Lucid Lane's patient-facing approach combines regular virtual coaching from licensed therapists and data-driven treatment planning. | ||||||||||||||||
| Roundtrip | Unspecified | $4.00 | Q3 | Motley Fool Ventures, Zoll Medical Corporation, UH Ventures and Gray Ferry Capital | The new funds will be put towards growing its geographical footprint and its sales force. It also plans to build up its portfolio of health plans and technology integrations. | The company offers a platform that coordinates patients' non-emergency medical transportation. | ||||||||||||||||
| SeamlessMD | Series A | $4.00 | Q3 | MEDTEQ+, Hikma Ventures, Anges Québec, AIoT Health and health IT entrepreneur Sanjay Malaviya. | SeamlessMD plans to deepen its library of digital care plans and improve the machine learning algorithm it employs to predict risk. | The SeamlessMD platform is used by health systems to monitor and stay connected with patients throughout a variety of different healthcare journeys, including surgery, oncology and chronic condition care. | ||||||||||||||||
| Story Health | Seed funding | $4 | Q4 | General Catalyst and Define Ventures | The funds accompanied Story's launch. | The company's tech guides patients and specialist physicians through a care journey with telemedicine, data models and analytics. | ||||||||||||||||
| Wellthy Therapeutics | pre-Series A | $4 | Q2 | Saama Capital | In addition to expanding into new regions, the company said that it will be using these funds to prepare for the launch of its digital respiratory therapeutic portfolio. | Wellthy is a digital-therapeutics company targeting chronic-disease prevention, management and reversal. | ||||||||||||||||
| DrDoctor | Series A | $3.80 | Q3 | Ananda Impact Ventures and 24Haymarket. | The funding will be used to expand its digital services platform and increase its reach across the U.K. Specifically, it will allow DrDoctor to expand its remote-patient-management and data solutions, reducing face-to-face appointments and helping improve clinical risk stratification. | DrDoctor offers a digital platform for patient communications and other hospital tasks. | ||||||||||||||||
| Wellsheet | Series A | $4 | Q2 | SpringTide Investments headed the round, which also saw contributions from BioAdvance and Newark Venture Partners. | The new funds will help his company build up its engineering and go-to-market teams. The money will also allow Wellsheet's platform to expand across platforms. | Wellsheet is a startup working to streamline EHR workflows via API. | ||||||||||||||||
| Gentem | Seed funding | 3.7 | Q1 | Susa Ventures, Village Global, Vulcan Capital, Hustle Fund, 500 Fintech, Social Starts, Great Oaks VC and other unnamed backers | The company wants to build on the early success its seen among beta clients by focusing on three core aspects of its business: operations, business growth and engineering of its tech platform. | Built for smaller practices, Gentem’s tech platform not only handles an office’s end-to-end billing and revenue cycle processes, but also pays physician customers up front for their services. | ||||||||||||||||
| ClinOne | Series A | $3.60 | Q1 | CU Healthcare Innovation Fund | The new funds are expected to help the company expand its product line and grow the business. | The platform works with pharma companies, research groups, and clinical trial sites in order to recruit appropriate patients for their trial. | ||||||||||||||||
| WiserCare | Unspecified | $3.60 | Q4 | UnityPoint Health Ventures, Abundant Venture Partners and "several" prior backers | WiserCare plans to build out the breadth and depth of its programs for health system and payer customers. | WiserCare offers a digital decision support tool that incorporates the patient's preferences for personalized care at scale. | ||||||||||||||||
| Inbox Health | N/A | $3.50 | Q1 | Healthy Ventures, Collaborative Fund. Commerce Ventures, Connecticut Innovations, I2BF Global Ventures and StartUp Health | The latest infusion of cash is expected to help the company to grow its footprint and customer base. | Inbox's system is able to automate patient communication for provider organizations and clarify questions for patients around their finances. | ||||||||||||||||
| Legacy | N/A | 3.5 | Q1 | Section 32, Y Combinator and Bain Capital Ventures | The company teased a handful of new products and services to be announced, including a "sperm score" rating. | Legacy’s business provides consumers with a mail-order semen collection kit and a subsequent digital fertility report. | ||||||||||||||||
| Blueprint | Seed round | $3.40 | Q4 | Bonfire Ventures, Lightbank and other unnamed angel investors | The funds will fuel new hires, increased marketing and brand awareness campaigns, and new developments for the product. | Blueprint is a Chicago-based startup building patient data collection software for mental health clinicians. | ||||||||||||||||
| Embodied Labs | Seed funding | $3 | Q1 | Ziegler Link·Age, The Venture Reality Fund, SustainVC, WXR Fund and ETF@JFFLabs | Embodied Labs is looking to increase its scale and reach. | Embodied Labs offers trainings for a variety of stakeholders, from hospices and healthcare systems to the call center of Best Buy’s senior products’ division. | ||||||||||||||||
| Adherium | Unspecified | $3 | Q4 | Viburnum | The company did not share immediate plans for the funds. | The company makes Bluetooth-connected sensors for use with prescription inhalers. | ||||||||||||||||
| Agamon | seed | $3 | Q2 | MMC Ventures, with contributions from InHealth Ventures, Seedcamp and Bayer G4A. | The company will be working toward scaling up global hospital deployments of its AI, which it will continue to train so that it can handle a wider range of clinical data. | It is a Tel Aviv, Israel-based startup using AI to format unstructured clinical data. | ||||||||||||||||
| Bloomer | Seed funding | $3 | Q1 | Material Impact, One Brave Idea and unnamed angel investors | The company plans to put the new funds towards supporting its pilots and increasing its clinical data. It will also use the funds to develop commercial products and the user experience. | The MIT-spinoff is putting electrocardiogram sensors and machine learning algorithms into the fabric of a bra. | ||||||||||||||||
| Coa | Seed funding | $3 | Q4 | Crosslink Ventures, RedSea Ventures, Alpaca VC, Casper founder Neil Parikh, professional basketball player Kevin Love and other angel investors | The money will help launch an online platform for employees, hire on a team of therapists, expand its program offerings and open up in-person locations. | Coa is an online platform for group and one-on-one mental health therapy, | ||||||||||||||||
| Emjoy | Seed funding | $3.00 | Q4 | JME Ventures and Nauta Capital | The funds will support development of new app content and collaborations. | The Barcelona-based company specializes in app-delivered content helping women understand their bodies and sexuality. | ||||||||||||||||
| Tava Health | Seed funding | $3 | Q2 | Peterson Ventures | The company said that it will be using these funds to expand the service into new geographic markets. | Tava works with employer customers to connect their employees with remote mental health therapy and a personalized treatment plan. | ||||||||||||||||
| Unlearn | Series A | $3 | Q4 | Eisai, Epic Ventures and Alumnia Ventures Group | The company did not disclose what the funding would be used for. | Unlearn uses its machine learning model, called Digenesis, to construct digital twins for participants in clinical trials. | ||||||||||||||||
| Verifiable | Seed funding | $3 | Q4 | Tiger Global, Liquid2 Ventures, Struck Capital, Soma Capital and individual backers | The company did not outline any specific plans for its new funds. | Verifiable has built an API to help organizations confirm the credentials of healthcare providers. | ||||||||||||||||
| Sift Healthcare | Unspecified | $2.80 | Q3 | Rock River Capital Partners, Winnebago Seed Fund and others. | These funds will help build out its data science and data engineering teams as it looks to meet new demands for its AI tools. | Sift is a healthcare payments and revenue cycle management startup. | ||||||||||||||||
| Deep01 | N/A | $3 | Q2 | ASUSTek, and included support from the Digital Economy Fund and BE Capital. | Deep01's software is has been cleared by the FDA, and according to the company is being used in six facilities in Taiwan. The company said that it also received its first purchase order in February. | It is a CT brain scan analysis software maker. | ||||||||||||||||
| Ophelia | Seed funding | $3 | Q2 | General Catalyst, Refactor Capital and Y Combinator | The company did not specify how the new funds would be used. | Ophelia combines an initial in-person visit and subsequent digital services to support substance abuse recovery. | ||||||||||||||||
| Stork Club | Seed funding | $3 | Q2 | Bowery Capital, Slow Ventures and angel investors | The startup did not specify how the funds would be used. | The concierge platform helps guide women through different phases of the maternity process, including diagnostics, egg and sperm freezing, IVF, surrogacy and adoption, childbirth, and breastfeeding support. | ||||||||||||||||
| Ōmcare | Unspecified | $2.50 | Q4 | Connect the Grey Investment Management | The money will be put towards commercializing the Ōmcare Home Health Hub product. | The medication adherence startup has built a video- and voice-call-enabled pill dispenser. | ||||||||||||||||
| OncoLens | Pre-Series A | $2.50 | Q1 | Atlanta Technology Angels and the Robbins Fund | This new infusion of cash is set to help the company grow its product and reach. | The startup has designed a platform that connects the care teams of patients with cancer in order to better coordinate on treatment plans. | ||||||||||||||||
| iWEECARE | pre-Series A | $2.40 | Q3 | TransLink Capital, Taiwan’s National Development Fund, BE Capital, Taiwan Surface Mounting Technology Corp (TSMT), NCTU Angel Club, Might Electronic, Verge HealthTech Fund and Darwin Venture. | The funds will be used to accelerate marketing activities to address the demand for remote patient monitoring technologies in the United States and China. | The company is the developer of the world’s smallest continuous temperature monitoring product, Temp Pal. | ||||||||||||||||
| Caliber FItness | Seed funding | $2.20 | Q4 | Trinity Ventures | Caliber did not outline any specific plans for its new funds. | The company offers one-on-one virtual coaching through a subscription membership program that provides users with a personalized curriculum and regular check-ins. | ||||||||||||||||
| Heart Health Intelligence | Seed funding | $2.20 | Q1 | Bemis Manufacturing Company, LaunchNY, RIT Venture Fund, Tech Coast Angels, Excell Partners and Impact Capital of New York | The new funds will be used to help the technology go through the process of FDA clearance, then get it up and running for commercialization. | The Rochester, New York-based startup is focused on developing the Heart Seat, which combines a toilet seat with a cardiovascular monitoring system. | ||||||||||||||||
| mediQuo | N/A | 2.16 | Q1 | Unnamed venture capital investors and family offices | The funding comes at a time when the Spanish startup plans to introduce a new app called mediQuo Pro, aimed at doctors and health professionals, who will be able to use it to manage patient consultations. | The company offers a healthcare management app targeting Spain and Latin America. | ||||||||||||||||
| LuminDx | Seed funding | $2.00 | Q3 | Argon VC, Flare Capital, Good Growth Capital, Techstars, TBD Angels, Andy Palmer, Bob Davoli, Esther Dyson and William Crawford | The company will now be able to access large image collections of skin conditions, improve its platform's accuracy and expand its team. | The company developed a smartphone app to help frontline providers identify likely skin conditions using machine learning and computer vision. | ||||||||||||||||
| Psyomics | Unspecified | $2 | Q4 | Undisclosed | Psyomics will use the money to bring its platform to market in the U.K. | Psyomics developed its Censeo platform with smart algorithms to mirror the face-to-face psychiatric assessment process. | ||||||||||||||||
| Mobio Interactive | seed funding | $1.80 | Q3 | Verge HealthTech Fund, Atlas Asset Management, Creative Ventures and SOSV. | The funds will be used to advance the deep tech and clinical validation of Am Mindfulness (Am), which was the first and currently only meditation app which the company claims to outperform placebo in randomized controlled trials. | Mobio Interactive develops and commercializes clinically validated and objectively quantified software to prevent, measure and treat mental illness. | ||||||||||||||||
| Repisodic | Seed funding | $1.75 | Q1 | American Enterprise Group | Repisodic plans to use the investment to buff its sales, marketing and technology teams through the first quarter of the new year. | Repisodic patient-facing, HIPAA-compliant tool looks to simplify discharge from care. | ||||||||||||||||
| Dozee | Unspecified | $1.70 | Q3 | Prime Venture Partners, YourNest Venture Capital and 3One4 Capital. | With this, company hopes to expand its market outreach and enhance the capabilities of its technology. Of note, it also is looking to global regulatory certifications such as FDA clearance. | Dozee is an Indian contactless remote-monitoring startup. | ||||||||||||||||
| Transformative | Seed funding | $1.70 | Q3 | Tera Ventures, Wellcome Trust and InHealth Ventures. | The startup will use its seed funding to obtain FDA clearance for its first product and to begin developing technologies that predict other life-threatening conditions. | Transformative’s software predicts sudden cardiac arrest by analysing data from patient monitoring devices. | ||||||||||||||||
| Every Mother | Seed funding | $1.50 | Q2 | Courtside Ventures, Serena Ventures, Techstar Ventures, The Fund and a handful of angel investors | This raise will help the company grow its service "to meet an ever-growing demand." | Every Mother's programs target fitness and physical challenges specific to pregnancy – for instance, repairing diastasis recti (ab separation) or relieving back pain and urinary incontinence. | ||||||||||||||||
| MedPilot | N/A | $1.50 | Q1 | Jumpstart, TurnCap, Northcoast Fund, Wavemaker Three-Sixty Health, Valley Growth Ventures, and Hudson River Capital Partners. | The company will put the new funds towards growing its team and developing its product. | This Cedar Sinai spinout focuses on using AI and other digital components to engage patients about their medical bills. | ||||||||||||||||
| Clearstep Health | pre-Seed funding | $1.30 | Q3 | RRE Ventures, Newark Venture Partners and OCA Ventures | The company will be making new hires to support product development and business development. | Clearstep makes an AI care navigation tool for in-person or virtual care. | ||||||||||||||||
| Fertifa | Unspecified | $1.30 | Q4 | Passion Capital and unnamed strategic angel investors | Fertifa plans to use the funding to enhance the services provided through its tech-enabled platform. | Fertifa acts as a digital fertility clinic for employees. | ||||||||||||||||
| MediShout | Seed round | $1.30 | Q4 | Episode 1 Ventures | The team plans to expand to over 20 hospitals in 18 months. | By using data and AI, Medishout's app predicts and prioritizes issues in the hospital’s facilities and equipment to ensure that patients can receive the most efficient care. | ||||||||||||||||
| Clementine | Unspecified | $1.10 | Q4 | Fortunis Capital | The company is looking to grow its business. | The femtech company provides virtual hypnotherapy sessions and wellness products to empower women to feel more confident. | ||||||||||||||||
| Navenio | Strategic investment | $1.10 | Q4 | Future Planet Capital | Navenio aims to use the funds for its intelligent workforce solution. | Navenio offers an indoors location tracking tool that helps to mitigate infection and cross-contamination in hospitals. | ||||||||||||||||
| Raccoon.World | Seed funding | $1.05 | Q3 | Quarter Partners and others | The funding will be used on the development of this new product functionality, as well as conducting additional clinical trials for it. | The startup will use the funding to enhance its Raccoon.Recovery rehabilitation platform in helping people recover after injuries and neurological diseases and aims to expand its existing markets in Germany and Poland. | ||||||||||||||||
| Relay One | N/A | $1 | Q1 | Cofounders Capital | The company said that it plans to put this $1 million towards growing its product and expanding its hospital network. | The North Carolina-based startup has developed a software that lets surgeons and healthcare providers communicate with medical-device vendors about cases. | ||||||||||||||||
| Navenio | N/A | $1 | Q2 | Innovate UK | The money secured from the Fast Start fund will be used to expand operations of the company’s "Intelligent Workforce Solution." | Navenio develops infrastructure-free location-based technologies that support apps and digital platforms across various sectors including health. | ||||||||||||||||
| Udok | Unspecified | $0.60 | Q4 | FinX Capital | The funds will be used to expand its network and technology and also aims to provide access to a Udok virtual practice at close to 200 Clicks Pharmacies countrywide. | Udok runs a Connected Care Platform using proprietary intellectual property developed in-house. | ||||||||||||||||
| HealtheMed | Seed funding | undisclosed | Q3 | The round was funded by angel investors. | The company said that its seed funding would help launch this service, and expanded into additional U.S. markets. | HealtheMed's approach relies on a two-way synchronous communication system consisting of a large TV, attached cameras and a microphone. This system is installed in Minnesota Medicaid members' homes through a partnership with Best Buy's Geek Squad | ||||||||||||||||
| Neuronostics | Unspecified | undisclosed | Q3 | unspecified | The company received funds to develop an AI-based system for more accurate diagnosis of epilepsy and to monitor response to treatment of anti-epileptic drugs (AEDs). | The platform is called BioEp and works by creating mathematical models of the brain using segments of electroencephalogram (EEG) recordings. | ||||||||||||||||
| Aaptiv | N/A | Undisclosed | Q2 | Insight Partners | The startup said that it will flesh out its enterprise API offering, allowing classes to be played through outside platforms. | Aaptiv delivers trainer-led fitness workouts and wellness sessions. | ||||||||||||||||
| Alodokter | Series C extension | Undisclosed | Q4 | MDI Ventures, Sequis, Golden Gate Ventures, Heritas and Hera Capital | The company will use the funds to scale its availability to Indonesian users and expand its offerings. | The all-in-one app offers a wide array of services around telemedicine such as offline doctor booking, insurance services and digital healthcare content. | ||||||||||||||||
| Celsium | Unspecified | Undisclosed | Q3 | Growthdeck | The funds will support Celsium's expansion. | Celsium’s device is an armpit-mounted temperature sensor, which connects via Bluetooth to a smart monitoring platform. | ||||||||||||||||
| CLIMBR | Unspecified | Undisclosed | Q4 | KBW-Ventures, Marco Borges an other unnamed backers | With this raise, the company will work to launch its products for at-home and commercial customers. | The fitness company's patent-pending exercise machine will include a touch display, an integrated audio system, on-demand live classes and a data-tracking companion app. | ||||||||||||||||
| CXS Growth | N/A | Undisclosed | Q2 | Humanica and HSBC | CXA Group further customize its platform from a software engineering perspective, which can then be white-labelled and used separately by each bank in the Asia region and offered to their base of commercial banking clients. | CXA offers an employee benefits and wellness marketplace. | ||||||||||||||||
| DocASAP | N/A | Undisclosed | Q2 | Optum Ventures | It will now be turning its attention toward payer-provider network growth and platform advancement. | The company is a patient access, engagement and navigation platform | ||||||||||||||||
| Homage | Series B | Undisclosed | Q1 | EV Growth, Alternatve Ventures, KDV Capital and HealthXCapital | With the injection of new funds, Homage will increase the scale of its operations via partnerships and internal investments. | Launched in 2017, Homage delivers personalized and holistic care to individuals, families, and organizations to enable wellness and recovery. | ||||||||||||||||
| Kaizen Health | Series B | Undisclosed | Q1 | UnityPoint Health Ventures | The latest raise will help the company expand its sales and account management teams while fleshing out its existing platform. | Kaizen’s tech helps health systems, payers, senior living groups and other organizations simplify the ordering and coordination of NEMT for individuals | ||||||||||||||||
| Quantum Health | Unspecified | Undisclosed | Q4 | Warburg Pincus | The investment will aid Quantum Health in improving its technology platform and service delivery capabilities for its customer base of self-insured employers. | Quantum Health offers a care navigation and guidance platform. | ||||||||||||||||
| Swoop Aero | Series A | Undisclosed | Q2 | Right Click Capital and Tempus Partners | The startup will use the latest eight figure sum capital injection to establish a presence in Australia and New Zealand (ANZ), as well as expand its service offering across the medical logistics space. | Swoop Aero says it aims to provide one hundred million people with better access to healthcare by 2025. | ||||||||||||||||
